<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for na_pos 1605120323325 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KEGG_RIBOSOME'>KEGG_RIBOSOME</a></td><td><a href='KEGG_RIBOSOME.html'>Details ...</a></td><td>78</td><td>0.90</td><td>4.84</td><td>0.000</td><td>0.000</td><td>0.000</td><td>128</td><td>tags=90%, list=10%, signal=94%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS'>WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS</a></td><td><a href='WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS.html'>Details ...</a></td><td>77</td><td>0.91</td><td>4.75</td><td>0.000</td><td>0.000</td><td>0.000</td><td>128</td><td>tags=91%, list=10%, signal=95%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION'>REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION</a></td><td><a href='REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION.html'>Details ...</a></td><td>84</td><td>0.89</td><td>4.75</td><td>0.000</td><td>0.000</td><td>0.000</td><td>157</td><td>tags=90%, list=12%, signal=96%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY'>REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY</a></td><td><a href='REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY.html'>Details ...</a></td><td>83</td><td>0.88</td><td>4.74</td><td>0.000</td><td>0.000</td><td>0.000</td><td>128</td><td>tags=87%, list=10%, signal=90%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_NONSENSE_MEDIATED_DECAY_NMD_'>REACTOME_NONSENSE_MEDIATED_DECAY_NMD_</a></td><td><a href='REACTOME_NONSENSE_MEDIATED_DECAY_NMD_.html'>Details ...</a></td><td>85</td><td>0.88</td><td>4.71</td><td>0.000</td><td>0.000</td><td>0.000</td><td>128</td><td>tags=84%, list=10%, signal=87%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_INFLUENZA_INFECTION'>REACTOME_INFLUENZA_INFECTION</a></td><td><a href='REACTOME_INFLUENZA_INFECTION.html'>Details ...</a></td><td>87</td><td>0.87</td><td>4.68</td><td>0.000</td><td>0.000</td><td>0.000</td><td>128</td><td>tags=83%, list=10%, signal=86%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE'>REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE</a></td><td><a href='REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE.html'>Details ...</a></td><td>83</td><td>0.88</td><td>4.68</td><td>0.000</td><td>0.000</td><td>0.000</td><td>128</td><td>tags=86%, list=10%, signal=89%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_RRNA_PROCESSING'>REACTOME_RRNA_PROCESSING</a></td><td><a href='REACTOME_RRNA_PROCESSING.html'>Details ...</a></td><td>92</td><td>0.86</td><td>4.67</td><td>0.000</td><td>0.000</td><td>0.000</td><td>156</td><td>tags=83%, list=12%, signal=87%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_SELENOAMINO_ACID_METABOLISM'>REACTOME_SELENOAMINO_ACID_METABOLISM</a></td><td><a href='REACTOME_SELENOAMINO_ACID_METABOLISM.html'>Details ...</a></td><td>82</td><td>0.89</td><td>4.66</td><td>0.000</td><td>0.000</td><td>0.000</td><td>128</td><td>tags=87%, list=10%, signal=90%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_ROBO_RECEPTORS'>REACTOME_SIGNALING_BY_ROBO_RECEPTORS</a></td><td><a href='REACTOME_SIGNALING_BY_ROBO_RECEPTORS.html'>Details ...</a></td><td>100</td><td>0.82</td><td>4.62</td><td>0.000</td><td>0.000</td><td>0.000</td><td>128</td><td>tags=71%, list=10%, signal=73%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_EUKARYOTIC_TRANSLATION_INITIATION'>REACTOME_EUKARYOTIC_TRANSLATION_INITIATION</a></td><td><a href='REACTOME_EUKARYOTIC_TRANSLATION_INITIATION.html'>Details ...</a></td><td>96</td><td>0.83</td><td>4.53</td><td>0.000</td><td>0.000</td><td>0.000</td><td>128</td><td>tags=75%, list=10%, signal=77%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS'>REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS</a></td><td><a href='REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS.html'>Details ...</a></td><td>99</td><td>0.83</td><td>4.48</td><td>0.000</td><td>0.000</td><td>0.000</td><td>128</td><td>tags=72%, list=10%, signal=74%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES'>REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES</a></td><td><a href='REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES.html'>Details ...</a></td><td>112</td><td>0.77</td><td>4.31</td><td>0.000</td><td>0.000</td><td>0.000</td><td>128</td><td>tags=63%, list=10%, signal=64%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_TRANSLATION'>REACTOME_TRANSLATION</a></td><td><a href='REACTOME_TRANSLATION.html'>Details ...</a></td><td>126</td><td>0.75</td><td>4.28</td><td>0.000</td><td>0.000</td><td>0.000</td><td>210</td><td>tags=68%, list=17%, signal=74%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_NERVOUS_SYSTEM_DEVELOPMENT'>REACTOME_NERVOUS_SYSTEM_DEVELOPMENT</a></td><td><a href='REACTOME_NERVOUS_SYSTEM_DEVELOPMENT.html'>Details ...</a></td><td>129</td><td>0.74</td><td>4.20</td><td>0.000</td><td>0.000</td><td>0.000</td><td>134</td><td>tags=57%, list=11%, signal=58%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI'>REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI</a></td><td><a href='REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI.html'>Details ...</a></td><td>143</td><td>0.71</td><td>4.20</td><td>0.000</td><td>0.000</td><td>0.000</td><td>128</td><td>tags=55%, list=10%, signal=55%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_RNA'>REACTOME_METABOLISM_OF_RNA</a></td><td><a href='REACTOME_METABOLISM_OF_RNA.html'>Details ...</a></td><td>177</td><td>0.69</td><td>4.17</td><td>0.000</td><td>0.000</td><td>0.000</td><td>211</td><td>tags=58%, list=17%, signal=60%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES'>BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES</a></td><td><a href='BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES.html'>Details ...</a></td><td>49</td><td>0.83</td><td>3.97</td><td>0.000</td><td>0.000</td><td>0.000</td><td>157</td><td>tags=84%, list=12%, signal=92%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_DEVELOPMENTAL_BIOLOGY'>REACTOME_DEVELOPMENTAL_BIOLOGY</a></td><td><a href='REACTOME_DEVELOPMENTAL_BIOLOGY.html'>Details ...</a></td><td>167</td><td>0.66</td><td>3.97</td><td>0.000</td><td>0.000</td><td>0.000</td><td>134</td><td>tags=47%, list=11%, signal=46%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_INFECTIOUS_DISEASE'>REACTOME_INFECTIOUS_DISEASE</a></td><td><a href='REACTOME_INFECTIOUS_DISEASE.html'>Details ...</a></td><td>158</td><td>0.64</td><td>3.79</td><td>0.000</td><td>0.000</td><td>0.000</td><td>141</td><td>tags=50%, list=11%, signal=49%</td></tr><tr><td class='lessen'>21</td><td>REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S</td><td></td><td>47</td><td>0.79</td><td>3.72</td><td>0.000</td><td>0.000</td><td>0.000</td><td>210</td><td>tags=81%, list=17%, signal=93%</td></tr><tr><td class='lessen'>22</td><td>HSIAO_HOUSEKEEPING_GENES</td><td></td><td>195</td><td>0.59</td><td>3.64</td><td>0.000</td><td>0.000</td><td>0.000</td><td>232</td><td>tags=52%, list=18%, signal=54%</td></tr><tr><td class='lessen'>23</td><td>CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP</td><td></td><td>39</td><td>0.79</td><td>3.60</td><td>0.000</td><td>0.000</td><td>0.000</td><td>157</td><td>tags=77%, list=12%, signal=85%</td></tr><tr><td class='lessen'>24</td><td>PECE_MAMMARY_STEM_CELL_UP</td><td></td><td>60</td><td>0.73</td><td>3.56</td><td>0.000</td><td>0.000</td><td>0.000</td><td>134</td><td>tags=62%, list=11%, signal=66%</td></tr><tr><td class='lessen'>25</td><td>MARTENS_TRETINOIN_RESPONSE_DN</td><td></td><td>169</td><td>0.58</td><td>3.48</td><td>0.000</td><td>0.000</td><td>0.000</td><td>321</td><td>tags=64%, list=25%, signal=74%</td></tr><tr><td class='lessen'>26</td><td>OSMAN_BLADDER_CANCER_DN</td><td></td><td>80</td><td>0.65</td><td>3.41</td><td>0.000</td><td>0.000</td><td>0.000</td><td>169</td><td>tags=58%, list=13%, signal=62%</td></tr><tr><td class='lessen'>27</td><td>TIEN_INTESTINE_PROBIOTICS_6HR_UP</td><td></td><td>33</td><td>0.78</td><td>3.35</td><td>0.000</td><td>0.000</td><td>0.000</td><td>164</td><td>tags=82%, list=13%, signal=92%</td></tr><tr><td class='lessen'>28</td><td>JISON_SICKLE_CELL_DISEASE_DN</td><td></td><td>61</td><td>0.66</td><td>3.31</td><td>0.000</td><td>0.000</td><td>0.000</td><td>243</td><td>tags=66%, list=19%, signal=77%</td></tr><tr><td class='lessen'>29</td><td>WANG_TUMOR_INVASIVENESS_UP</td><td></td><td>128</td><td>0.57</td><td>3.28</td><td>0.000</td><td>0.000</td><td>0.000</td><td>318</td><td>tags=63%, list=25%, signal=75%</td></tr><tr><td class='lessen'>30</td><td>DANG_MYC_TARGETS_UP</td><td></td><td>59</td><td>0.64</td><td>3.19</td><td>0.000</td><td>0.000</td><td>0.000</td><td>219</td><td>tags=59%, list=17%, signal=68%</td></tr><tr><td class='lessen'>31</td><td>PUJANA_BRCA1_PCC_NETWORK</td><td></td><td>273</td><td>0.49</td><td>3.17</td><td>0.000</td><td>0.000</td><td>0.000</td><td>476</td><td>tags=68%, list=37%, signal=86%</td></tr><tr><td class='lessen'>32</td><td>CAIRO_HEPATOBLASTOMA_CLASSES_UP</td><td></td><td>135</td><td>0.52</td><td>3.05</td><td>0.000</td><td>0.000</td><td>0.000</td><td>390</td><td>tags=61%, list=31%, signal=79%</td></tr><tr><td class='lessen'>33</td><td>YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP</td><td></td><td>25</td><td>0.75</td><td>3.00</td><td>0.000</td><td>0.000</td><td>0.000</td><td>135</td><td>tags=72%, list=11%, signal=79%</td></tr><tr><td class='lessen'>34</td><td>BILANGES_SERUM_RESPONSE_TRANSLATION</td><td></td><td>20</td><td>0.80</td><td>3.00</td><td>0.000</td><td>0.000</td><td>0.000</td><td>200</td><td>tags=85%, list=16%, signal=99%</td></tr><tr><td class='lessen'>35</td><td>LEE_LIVER_CANCER_SURVIVAL_DN</td><td></td><td>69</td><td>0.59</td><td>2.99</td><td>0.000</td><td>0.000</td><td>0.000</td><td>304</td><td>tags=61%, list=24%, signal=76%</td></tr><tr><td class='lessen'>36</td><td>LI_AMPLIFIED_IN_LUNG_CANCER</td><td></td><td>72</td><td>0.57</td><td>2.99</td><td>0.000</td><td>0.000</td><td>0.000</td><td>292</td><td>tags=65%, list=23%, signal=80%</td></tr><tr><td class='lessen'>37</td><td>TIEN_INTESTINE_PROBIOTICS_24HR_DN</td><td></td><td>66</td><td>0.58</td><td>2.98</td><td>0.000</td><td>0.000</td><td>0.000</td><td>164</td><td>tags=48%, list=13%, signal=53%</td></tr><tr><td class='lessen'>38</td><td>POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN</td><td></td><td>18</td><td>0.81</td><td>2.94</td><td>0.000</td><td>0.000</td><td>0.000</td><td>149</td><td>tags=78%, list=12%, signal=87%</td></tr><tr><td class='lessen'>39</td><td>REACTOME_DISEASE</td><td></td><td>230</td><td>0.47</td><td>2.91</td><td>0.000</td><td>0.000</td><td>0.000</td><td>134</td><td>tags=35%, list=11%, signal=32%</td></tr><tr><td class='lessen'>40</td><td>POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN</td><td></td><td>15</td><td>0.85</td><td>2.87</td><td>0.000</td><td>0.000</td><td>0.000</td><td>200</td><td>tags=100%, list=16%, signal=117%</td></tr><tr><td class='lessen'>41</td><td>FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP</td><td></td><td>21</td><td>0.77</td><td>2.82</td><td>0.000</td><td>0.000</td><td>0.000</td><td>152</td><td>tags=71%, list=12%, signal=80%</td></tr><tr><td class='lessen'>42</td><td>PUJANA_ATM_PCC_NETWORK</td><td></td><td>196</td><td>0.46</td><td>2.80</td><td>0.000</td><td>0.000</td><td>0.000</td><td>295</td><td>tags=47%, list=23%, signal=52%</td></tr><tr><td class='lessen'>43</td><td>WONG_EMBRYONIC_STEM_CELL_CORE</td><td></td><td>93</td><td>0.51</td><td>2.78</td><td>0.000</td><td>0.000</td><td>0.000</td><td>242</td><td>tags=46%, list=19%, signal=53%</td></tr><tr><td class='lessen'>44</td><td>PUJANA_CHEK2_PCC_NETWORK</td><td></td><td>167</td><td>0.46</td><td>2.77</td><td>0.000</td><td>0.000</td><td>0.000</td><td>524</td><td>tags=75%, list=41%, signal=111%</td></tr><tr><td class='lessen'>45</td><td>MODY_HIPPOCAMPUS_PRENATAL</td><td></td><td>25</td><td>0.70</td><td>2.76</td><td>0.000</td><td>0.000</td><td>0.000</td><td>162</td><td>tags=64%, list=13%, signal=72%</td></tr><tr><td class='lessen'>46</td><td>DANG_BOUND_BY_MYC</td><td></td><td>166</td><td>0.44</td><td>2.68</td><td>0.000</td><td>0.000</td><td>0.000</td><td>294</td><td>tags=45%, list=23%, signal=51%</td></tr><tr><td class='lessen'>47</td><td>REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA</td><td></td><td>57</td><td>0.54</td><td>2.66</td><td>0.000</td><td>0.000</td><td>0.000</td><td>449</td><td>tags=79%, list=35%, signal=117%</td></tr><tr><td class='lessen'>48</td><td>SANA_RESPONSE_TO_IFNG_DN</td><td></td><td>32</td><td>0.62</td><td>2.65</td><td>0.000</td><td>0.000</td><td>0.000</td><td>307</td><td>tags=69%, list=24%, signal=88%</td></tr><tr><td class='lessen'>49</td><td>ANDERSEN_LIVER_CANCER_KRT19_UP</td><td></td><td>20</td><td>0.70</td><td>2.61</td><td>0.000</td><td>0.000</td><td>0.001</td><td>288</td><td>tags=80%, list=23%, signal=102%</td></tr><tr><td class='lessen'>50</td><td>YAGI_AML_WITH_INV_16_TRANSLOCATION</td><td></td><td>60</td><td>0.52</td><td>2.61</td><td>0.000</td><td>0.000</td><td>0.001</td><td>170</td><td>tags=50%, list=13%, signal=55%</td></tr><tr><td class='lessen'>51</td><td>KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP</td><td></td><td>136</td><td>0.44</td><td>2.58</td><td>0.000</td><td>0.000</td><td>0.001</td><td>216</td><td>tags=36%, list=17%, signal=39%</td></tr><tr><td class='lessen'>52</td><td>DAZARD_UV_RESPONSE_CLUSTER_G1</td><td></td><td>23</td><td>0.66</td><td>2.58</td><td>0.000</td><td>0.000</td><td>0.001</td><td>145</td><td>tags=61%, list=11%, signal=67%</td></tr><tr><td class='lessen'>53</td><td>BENPORATH_MYC_MAX_TARGETS</td><td></td><td>115</td><td>0.46</td><td>2.57</td><td>0.000</td><td>0.000</td><td>0.001</td><td>351</td><td>tags=54%, list=28%, signal=68%</td></tr><tr><td class='lessen'>54</td><td>REACTOME_MRNA_SPLICING</td><td></td><td>54</td><td>0.54</td><td>2.56</td><td>0.000</td><td>0.000</td><td>0.001</td><td>449</td><td>tags=78%, list=35%, signal=115%</td></tr><tr><td class='lessen'>55</td><td>IRITANI_MAD1_TARGETS_DN</td><td></td><td>17</td><td>0.71</td><td>2.54</td><td>0.000</td><td>0.000</td><td>0.002</td><td>111</td><td>tags=59%, list=9%, signal=64%</td></tr><tr><td class='lessen'>56</td><td>BOUDOUKHA_BOUND_BY_IGF2BP2</td><td></td><td>33</td><td>0.58</td><td>2.48</td><td>0.000</td><td>0.000</td><td>0.004</td><td>246</td><td>tags=58%, list=19%, signal=70%</td></tr><tr><td class='lessen'>57</td><td>ONKEN_UVEAL_MELANOMA_DN</td><td></td><td>87</td><td>0.45</td><td>2.47</td><td>0.000</td><td>0.000</td><td>0.004</td><td>144</td><td>tags=32%, list=11%, signal=34%</td></tr><tr><td class='lessen'>58</td><td>KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP</td><td></td><td>139</td><td>0.43</td><td>2.47</td><td>0.000</td><td>0.000</td><td>0.004</td><td>275</td><td>tags=41%, list=22%, signal=47%</td></tr><tr><td class='lessen'>59</td><td>HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP</td><td></td><td>16</td><td>0.72</td><td>2.45</td><td>0.000</td><td>0.000</td><td>0.004</td><td>288</td><td>tags=88%, list=23%, signal=112%</td></tr><tr><td class='lessen'>60</td><td>DODD_NASOPHARYNGEAL_CARCINOMA_DN</td><td></td><td>162</td><td>0.41</td><td>2.45</td><td>0.000</td><td>0.000</td><td>0.004</td><td>466</td><td>tags=61%, list=37%, signal=84%</td></tr><tr><td class='lessen'>61</td><td>ZAMORA_NOS2_TARGETS_UP</td><td></td><td>19</td><td>0.67</td><td>2.44</td><td>0.000</td><td>0.000</td><td>0.004</td><td>320</td><td>tags=79%, list=25%, signal=104%</td></tr><tr><td class='lessen'>62</td><td>BENPORATH_MYC_TARGETS_WITH_EBOX</td><td></td><td>55</td><td>0.50</td><td>2.44</td><td>0.000</td><td>0.000</td><td>0.004</td><td>288</td><td>tags=58%, list=23%, signal=72%</td></tr><tr><td class='lessen'>63</td><td>DARWICHE_PAPILLOMA_RISK_LOW_UP</td><td></td><td>32</td><td>0.57</td><td>2.40</td><td>0.000</td><td>0.000</td><td>0.005</td><td>380</td><td>tags=75%, list=30%, signal=104%</td></tr><tr><td class='lessen'>64</td><td>WP_MRNA_PROCESSING</td><td></td><td>43</td><td>0.52</td><td>2.40</td><td>0.000</td><td>0.000</td><td>0.005</td><td>488</td><td>tags=81%, list=38%, signal=128%</td></tr><tr><td class='lessen'>65</td><td>KEGG_SPLICEOSOME</td><td></td><td>40</td><td>0.53</td><td>2.40</td><td>0.000</td><td>0.000</td><td>0.007</td><td>332</td><td>tags=63%, list=26%, signal=82%</td></tr><tr><td class='lessen'>66</td><td>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN</td><td></td><td>20</td><td>0.64</td><td>2.39</td><td>0.000</td><td>0.000</td><td>0.007</td><td>169</td><td>tags=55%, list=13%, signal=62%</td></tr><tr><td class='lessen'>67</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2</td><td></td><td>31</td><td>0.57</td><td>2.38</td><td>0.000</td><td>0.000</td><td>0.010</td><td>414</td><td>tags=77%, list=33%, signal=112%</td></tr><tr><td class='lessen'>68</td><td>FISCHER_DREAM_TARGETS</td><td></td><td>108</td><td>0.42</td><td>2.37</td><td>0.000</td><td>0.000</td><td>0.014</td><td>532</td><td>tags=75%, list=42%, signal=118%</td></tr><tr><td class='lessen'>69</td><td>BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2</td><td></td><td>30</td><td>0.56</td><td>2.35</td><td>0.000</td><td>0.000</td><td>0.017</td><td>190</td><td>tags=47%, list=15%, signal=54%</td></tr><tr><td class='lessen'>70</td><td>DARWICHE_PAPILLOMA_RISK_HIGH_UP</td><td></td><td>29</td><td>0.57</td><td>2.35</td><td>0.000</td><td>0.000</td><td>0.017</td><td>380</td><td>tags=76%, list=30%, signal=106%</td></tr><tr><td class='lessen'>71</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP</td><td></td><td>101</td><td>0.42</td><td>2.33</td><td>0.000</td><td>0.000</td><td>0.023</td><td>227</td><td>tags=41%, list=18%, signal=45%</td></tr><tr><td class='lessen'>72</td><td>CHICAS_RB1_TARGETS_LOW_SERUM</td><td></td><td>27</td><td>0.57</td><td>2.31</td><td>0.000</td><td>0.001</td><td>0.031</td><td>450</td><td>tags=81%, list=35%, signal=123%</td></tr><tr><td class='lessen'>73</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>37</td><td>0.52</td><td>2.30</td><td>0.000</td><td>0.001</td><td>0.033</td><td>344</td><td>tags=62%, list=27%, signal=83%</td></tr><tr><td class='lessen'>74</td><td>REACTOME_MRNA_SPLICING_MINOR_PATHWAY</td><td></td><td>18</td><td>0.64</td><td>2.28</td><td>0.000</td><td>0.001</td><td>0.044</td><td>437</td><td>tags=94%, list=34%, signal=142%</td></tr><tr><td class='lessen'>75</td><td>DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP</td><td></td><td>30</td><td>0.54</td><td>2.28</td><td>0.000</td><td>0.001</td><td>0.044</td><td>380</td><td>tags=73%, list=30%, signal=102%</td></tr><tr><td class='lessen'>76</td><td>LEE_LIVER_CANCER_MYC_UP</td><td></td><td>19</td><td>0.62</td><td>2.27</td><td>0.000</td><td>0.001</td><td>0.051</td><td>134</td><td>tags=47%, list=11%, signal=52%</td></tr><tr><td class='lessen'>77</td><td>RHODES_CANCER_META_SIGNATURE</td><td></td><td>24</td><td>0.59</td><td>2.27</td><td>0.000</td><td>0.001</td><td>0.051</td><td>186</td><td>tags=50%, list=15%, signal=57%</td></tr><tr><td class='lessen'>78</td><td>MALONEY_RESPONSE_TO_17AAG_DN</td><td></td><td>40</td><td>0.51</td><td>2.27</td><td>0.000</td><td>0.001</td><td>0.051</td><td>254</td><td>tags=48%, list=20%, signal=57%</td></tr><tr><td class='lessen'>79</td><td>BHATTACHARYA_EMBRYONIC_STEM_CELL</td><td></td><td>27</td><td>0.57</td><td>2.26</td><td>0.000</td><td>0.001</td><td>0.052</td><td>156</td><td>tags=48%, list=12%, signal=54%</td></tr><tr><td class='lessen'>80</td><td>BORCZUK_MALIGNANT_MESOTHELIOMA_UP</td><td></td><td>64</td><td>0.44</td><td>2.25</td><td>0.000</td><td>0.001</td><td>0.057</td><td>524</td><td>tags=77%, list=41%, signal=124%</td></tr><tr><td class='lessen'>81</td><td>FERNANDEZ_BOUND_BY_MYC</td><td></td><td>34</td><td>0.52</td><td>2.24</td><td>0.000</td><td>0.001</td><td>0.065</td><td>288</td><td>tags=62%, list=23%, signal=78%</td></tr><tr><td class='lessen'>82</td><td>SANSOM_APC_TARGETS_REQUIRE_MYC</td><td></td><td>27</td><td>0.55</td><td>2.24</td><td>0.000</td><td>0.001</td><td>0.065</td><td>464</td><td>tags=81%, list=37%, signal=126%</td></tr><tr><td class='lessen'>83</td><td>DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN</td><td></td><td>30</td><td>0.55</td><td>2.23</td><td>0.000</td><td>0.001</td><td>0.075</td><td>134</td><td>tags=50%, list=11%, signal=55%</td></tr><tr><td class='lessen'>84</td><td>FEVR_CTNNB1_TARGETS_DN</td><td></td><td>106</td><td>0.40</td><td>2.21</td><td>0.000</td><td>0.001</td><td>0.094</td><td>343</td><td>tags=51%, list=27%, signal=64%</td></tr><tr><td class='lessen'>85</td><td>YAMAZAKI_TCEB3_TARGETS_DN</td><td></td><td>44</td><td>0.47</td><td>2.19</td><td>0.000</td><td>0.002</td><td>0.111</td><td>373</td><td>tags=61%, list=29%, signal=84%</td></tr><tr><td class='lessen'>86</td><td>WANG_CISPLATIN_RESPONSE_AND_XPC_UP</td><td></td><td>27</td><td>0.54</td><td>2.18</td><td>0.000</td><td>0.002</td><td>0.123</td><td>368</td><td>tags=67%, list=29%, signal=92%</td></tr><tr><td class='lessen'>87</td><td>MUELLER_PLURINET</td><td></td><td>64</td><td>0.43</td><td>2.16</td><td>0.000</td><td>0.002</td><td>0.130</td><td>342</td><td>tags=50%, list=27%, signal=65%</td></tr><tr><td class='lessen'>88</td><td>TAKAO_RESPONSE_TO_UVB_RADIATION_UP</td><td></td><td>35</td><td>0.49</td><td>2.15</td><td>0.000</td><td>0.002</td><td>0.147</td><td>246</td><td>tags=46%, list=19%, signal=55%</td></tr><tr><td class='lessen'>89</td><td>TARTE_PLASMA_CELL_VS_PLASMABLAST_UP</td><td></td><td>58</td><td>0.43</td><td>2.14</td><td>0.000</td><td>0.002</td><td>0.161</td><td>124</td><td>tags=36%, list=10%, signal=38%</td></tr><tr><td class='lessen'>90</td><td>WP_TRANSLATION_FACTORS</td><td></td><td>26</td><td>0.53</td><td>2.14</td><td>0.000</td><td>0.003</td><td>0.169</td><td>584</td><td>tags=96%, list=46%, signal=174%</td></tr><tr><td class='lessen'>91</td><td>SANSOM_APC_TARGETS_UP</td><td></td><td>22</td><td>0.56</td><td>2.13</td><td>0.002</td><td>0.003</td><td>0.181</td><td>234</td><td>tags=55%, list=18%, signal=66%</td></tr><tr><td class='lessen'>92</td><td>GRADE_COLON_AND_RECTAL_CANCER_UP</td><td></td><td>65</td><td>0.42</td><td>2.13</td><td>0.000</td><td>0.003</td><td>0.201</td><td>470</td><td>tags=65%, list=37%, signal=97%</td></tr><tr><td class='lessen'>93</td><td>WP_VEGFAVEGFR2_SIGNALING_PATHWAY</td><td></td><td>76</td><td>0.41</td><td>2.12</td><td>0.000</td><td>0.003</td><td>0.220</td><td>217</td><td>tags=36%, list=17%, signal=40%</td></tr><tr><td class='lessen'>94</td><td>MARTINEZ_RB1_AND_TP53_TARGETS_DN</td><td></td><td>94</td><td>0.39</td><td>2.11</td><td>0.000</td><td>0.003</td><td>0.220</td><td>238</td><td>tags=37%, list=19%, signal=42%</td></tr><tr><td class='lessen'>95</td><td>KARLSSON_TGFB1_TARGETS_UP</td><td></td><td>46</td><td>0.46</td><td>2.11</td><td>0.000</td><td>0.004</td><td>0.231</td><td>459</td><td>tags=70%, list=36%, signal=105%</td></tr><tr><td class='lessen'>96</td><td>LUI_THYROID_CANCER_CLUSTER_3</td><td></td><td>19</td><td>0.58</td><td>2.10</td><td>0.000</td><td>0.004</td><td>0.255</td><td>200</td><td>tags=58%, list=16%, signal=68%</td></tr><tr><td class='lessen'>97</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP</td><td></td><td>36</td><td>0.48</td><td>2.08</td><td>0.000</td><td>0.004</td><td>0.281</td><td>344</td><td>tags=61%, list=27%, signal=81%</td></tr><tr><td class='lessen'>98</td><td>KIM_MYC_AMPLIFICATION_TARGETS_UP</td><td></td><td>37</td><td>0.48</td><td>2.08</td><td>0.000</td><td>0.004</td><td>0.289</td><td>143</td><td>tags=35%, list=11%, signal=38%</td></tr><tr><td class='lessen'>99</td><td>HILLION_HMGA1_TARGETS</td><td></td><td>24</td><td>0.53</td><td>2.08</td><td>0.002</td><td>0.004</td><td>0.289</td><td>219</td><td>tags=58%, list=17%, signal=69%</td></tr><tr><td class='lessen'>100</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13</td><td></td><td>48</td><td>0.45</td><td>2.07</td><td>0.000</td><td>0.005</td><td>0.306</td><td>413</td><td>tags=65%, list=32%, signal=92%</td></tr><tr><td class='lessen'>101</td><td>HILLION_HMGA1B_TARGETS</td><td></td><td>25</td><td>0.53</td><td>2.06</td><td>0.002</td><td>0.005</td><td>0.322</td><td>202</td><td>tags=56%, list=16%, signal=65%</td></tr><tr><td class='lessen'>102</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S2</td><td></td><td>28</td><td>0.50</td><td>2.05</td><td>0.000</td><td>0.005</td><td>0.345</td><td>226</td><td>tags=46%, list=18%, signal=55%</td></tr><tr><td class='lessen'>103</td><td>SWEET_KRAS_ONCOGENIC_SIGNATURE</td><td></td><td>30</td><td>0.50</td><td>2.05</td><td>0.000</td><td>0.005</td><td>0.346</td><td>159</td><td>tags=43%, list=13%, signal=48%</td></tr><tr><td class='lessen'>104</td><td>MISSIAGLIA_REGULATED_BY_METHYLATION_DN</td><td></td><td>30</td><td>0.49</td><td>2.01</td><td>0.000</td><td>0.007</td><td>0.459</td><td>368</td><td>tags=63%, list=29%, signal=87%</td></tr><tr><td class='lessen'>105</td><td>RODWELL_AGING_KIDNEY_UP</td><td></td><td>53</td><td>0.42</td><td>2.01</td><td>0.000</td><td>0.007</td><td>0.464</td><td>183</td><td>tags=40%, list=14%, signal=44%</td></tr><tr><td class='lessen'>106</td><td>KOBAYASHI_EGFR_SIGNALING_24HR_DN</td><td></td><td>35</td><td>0.46</td><td>2.01</td><td>0.000</td><td>0.008</td><td>0.472</td><td>522</td><td>tags=80%, list=41%, signal=132%</td></tr><tr><td class='lessen'>107</td><td>BENPORATH_SOX2_TARGETS</td><td></td><td>83</td><td>0.37</td><td>2.01</td><td>0.000</td><td>0.008</td><td>0.482</td><td>192</td><td>tags=30%, list=15%, signal=33%</td></tr><tr><td class='lessen'>108</td><td>NUYTTEN_EZH2_TARGETS_DN</td><td></td><td>103</td><td>0.36</td><td>2.00</td><td>0.000</td><td>0.008</td><td>0.509</td><td>453</td><td>tags=56%, list=36%, signal=80%</td></tr><tr><td class='lessen'>109</td><td>SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM</td><td></td><td>43</td><td>0.43</td><td>1.99</td><td>0.000</td><td>0.009</td><td>0.533</td><td>527</td><td>tags=74%, list=41%, signal=123%</td></tr><tr><td class='lessen'>110</td><td>RODWELL_AGING_KIDNEY_NO_BLOOD_UP</td><td></td><td>27</td><td>0.50</td><td>1.99</td><td>0.002</td><td>0.009</td><td>0.544</td><td>183</td><td>tags=48%, list=14%, signal=55%</td></tr><tr><td class='lessen'>111</td><td>CUI_TCF21_TARGETS_2_UP</td><td></td><td>62</td><td>0.40</td><td>1.99</td><td>0.000</td><td>0.009</td><td>0.555</td><td>307</td><td>tags=48%, list=24%, signal=61%</td></tr><tr><td class='lessen'>112</td><td>HORIUCHI_WTAP_TARGETS_DN</td><td></td><td>57</td><td>0.41</td><td>1.98</td><td>0.002</td><td>0.010</td><td>0.590</td><td>518</td><td>tags=74%, list=41%, signal=119%</td></tr><tr><td class='lessen'>113</td><td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN</td><td></td><td>95</td><td>0.36</td><td>1.97</td><td>0.000</td><td>0.010</td><td>0.605</td><td>428</td><td>tags=55%, list=34%, signal=76%</td></tr><tr><td class='lessen'>114</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_T7</td><td></td><td>26</td><td>0.48</td><td>1.96</td><td>0.004</td><td>0.011</td><td>0.628</td><td>257</td><td>tags=54%, list=20%, signal=66%</td></tr><tr><td class='lessen'>115</td><td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN</td><td></td><td>19</td><td>0.55</td><td>1.95</td><td>0.005</td><td>0.012</td><td>0.650</td><td>177</td><td>tags=47%, list=14%, signal=54%</td></tr><tr><td class='lessen'>116</td><td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP</td><td></td><td>81</td><td>0.37</td><td>1.94</td><td>0.000</td><td>0.012</td><td>0.673</td><td>620</td><td>tags=80%, list=49%, signal=147%</td></tr><tr><td class='lessen'>117</td><td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST</td><td></td><td>49</td><td>0.42</td><td>1.94</td><td>0.000</td><td>0.012</td><td>0.676</td><td>406</td><td>tags=59%, list=32%, signal=84%</td></tr><tr><td class='lessen'>118</td><td>LEE_BMP2_TARGETS_DN</td><td></td><td>122</td><td>0.34</td><td>1.93</td><td>0.000</td><td>0.014</td><td>0.719</td><td>477</td><td>tags=57%, list=38%, signal=83%</td></tr><tr><td class='lessen'>119</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN</td><td></td><td>148</td><td>0.32</td><td>1.92</td><td>0.000</td><td>0.014</td><td>0.737</td><td>550</td><td>tags=66%, list=43%, signal=103%</td></tr><tr><td class='lessen'>120</td><td>JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP</td><td></td><td>22</td><td>0.51</td><td>1.92</td><td>0.006</td><td>0.015</td><td>0.747</td><td>265</td><td>tags=64%, list=21%, signal=79%</td></tr><tr><td class='lessen'>121</td><td>FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP</td><td></td><td>25</td><td>0.49</td><td>1.92</td><td>0.006</td><td>0.015</td><td>0.759</td><td>636</td><td>tags=96%, list=50%, signal=188%</td></tr><tr><td class='lessen'>122</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN</td><td></td><td>135</td><td>0.33</td><td>1.91</td><td>0.002</td><td>0.015</td><td>0.766</td><td>550</td><td>tags=68%, list=43%, signal=107%</td></tr><tr><td class='lessen'>123</td><td>LUI_TARGETS_OF_PAX8_PPARG_FUSION</td><td></td><td>23</td><td>0.49</td><td>1.91</td><td>0.004</td><td>0.016</td><td>0.780</td><td>200</td><td>tags=52%, list=16%, signal=61%</td></tr><tr><td class='lessen'>124</td><td>MARKEY_RB1_ACUTE_LOF_UP</td><td></td><td>48</td><td>0.41</td><td>1.90</td><td>0.000</td><td>0.017</td><td>0.811</td><td>273</td><td>tags=44%, list=21%, signal=54%</td></tr><tr><td class='lessen'>125</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14</td><td></td><td>45</td><td>0.41</td><td>1.90</td><td>0.000</td><td>0.017</td><td>0.812</td><td>634</td><td>tags=91%, list=50%, signal=175%</td></tr><tr><td class='lessen'>126</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_3_DN</td><td></td><td>25</td><td>0.48</td><td>1.90</td><td>0.000</td><td>0.017</td><td>0.814</td><td>279</td><td>tags=48%, list=22%, signal=60%</td></tr><tr><td class='lessen'>127</td><td>REACTOME_CELL_CYCLE</td><td></td><td>75</td><td>0.36</td><td>1.90</td><td>0.000</td><td>0.017</td><td>0.815</td><td>525</td><td>tags=65%, list=41%, signal=105%</td></tr><tr><td class='lessen'>128</td><td>PID_MYC_ACTIV_PATHWAY</td><td></td><td>25</td><td>0.48</td><td>1.90</td><td>0.006</td><td>0.017</td><td>0.815</td><td>219</td><td>tags=40%, list=17%, signal=47%</td></tr><tr><td class='lessen'>129</td><td>BIDUS_METASTASIS_UP</td><td></td><td>44</td><td>0.42</td><td>1.90</td><td>0.002</td><td>0.017</td><td>0.819</td><td>614</td><td>tags=86%, list=48%, signal=161%</td></tr><tr><td class='lessen'>130</td><td>EPPERT_PROGENITOR</td><td></td><td>19</td><td>0.53</td><td>1.89</td><td>0.002</td><td>0.017</td><td>0.827</td><td>390</td><td>tags=74%, list=31%, signal=105%</td></tr><tr><td class='lessen'>131</td><td>TARTE_PLASMA_CELL_VS_PLASMABLAST_DN</td><td></td><td>75</td><td>0.36</td><td>1.89</td><td>0.000</td><td>0.018</td><td>0.834</td><td>575</td><td>tags=79%, list=45%, signal=135%</td></tr><tr><td class='lessen'>132</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP</td><td></td><td>21</td><td>0.49</td><td>1.89</td><td>0.004</td><td>0.018</td><td>0.835</td><td>159</td><td>tags=38%, list=13%, signal=43%</td></tr><tr><td class='lessen'>133</td><td>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP</td><td></td><td>78</td><td>0.35</td><td>1.89</td><td>0.000</td><td>0.018</td><td>0.841</td><td>622</td><td>tags=82%, list=49%, signal=151%</td></tr><tr><td class='lessen'>134</td><td>RHODES_UNDIFFERENTIATED_CANCER</td><td></td><td>19</td><td>0.52</td><td>1.89</td><td>0.009</td><td>0.018</td><td>0.842</td><td>518</td><td>tags=84%, list=41%, signal=140%</td></tr><tr><td class='lessen'>135</td><td>BERENJENO_TRANSFORMED_BY_RHOA_UP</td><td></td><td>121</td><td>0.33</td><td>1.88</td><td>0.000</td><td>0.019</td><td>0.859</td><td>535</td><td>tags=67%, list=42%, signal=105%</td></tr><tr><td class='lessen'>136</td><td>DARWICHE_SKIN_TUMOR_PROMOTER_UP</td><td></td><td>22</td><td>0.49</td><td>1.88</td><td>0.008</td><td>0.019</td><td>0.867</td><td>416</td><td>tags=73%, list=33%, signal=106%</td></tr><tr><td class='lessen'>137</td><td>ZHANG_RESPONSE_TO_CANTHARIDIN_DN</td><td></td><td>22</td><td>0.49</td><td>1.87</td><td>0.006</td><td>0.020</td><td>0.894</td><td>400</td><td>tags=64%, list=31%, signal=91%</td></tr><tr><td class='lessen'>138</td><td>SANSOM_APC_MYC_TARGETS</td><td></td><td>28</td><td>0.46</td><td>1.87</td><td>0.007</td><td>0.020</td><td>0.897</td><td>387</td><td>tags=61%, list=30%, signal=85%</td></tr><tr><td class='lessen'>139</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP</td><td></td><td>15</td><td>0.56</td><td>1.87</td><td>0.004</td><td>0.021</td><td>0.900</td><td>252</td><td>tags=60%, list=20%, signal=74%</td></tr><tr><td class='lessen'>140</td><td>PUJANA_XPRSS_INT_NETWORK</td><td></td><td>27</td><td>0.46</td><td>1.86</td><td>0.006</td><td>0.021</td><td>0.907</td><td>633</td><td>tags=93%, list=50%, signal=181%</td></tr><tr><td class='lessen'>141</td><td>MILI_PSEUDOPODIA_CHEMOTAXIS_UP</td><td></td><td>15</td><td>0.56</td><td>1.85</td><td>0.009</td><td>0.023</td><td>0.924</td><td>190</td><td>tags=53%, list=15%, signal=62%</td></tr><tr><td class='lessen'>142</td><td>MARTINEZ_TP53_TARGETS_DN</td><td></td><td>99</td><td>0.34</td><td>1.85</td><td>0.000</td><td>0.023</td><td>0.926</td><td>238</td><td>tags=34%, list=19%, signal=39%</td></tr><tr><td class='lessen'>143</td><td>OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP</td><td></td><td>16</td><td>0.53</td><td>1.85</td><td>0.011</td><td>0.023</td><td>0.930</td><td>255</td><td>tags=63%, list=20%, signal=77%</td></tr><tr><td class='lessen'>144</td><td>SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP</td><td></td><td>25</td><td>0.47</td><td>1.84</td><td>0.009</td><td>0.024</td><td>0.938</td><td>525</td><td>tags=80%, list=41%, signal=134%</td></tr><tr><td class='lessen'>145</td><td>SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN</td><td></td><td>15</td><td>0.55</td><td>1.84</td><td>0.004</td><td>0.024</td><td>0.940</td><td>422</td><td>tags=80%, list=33%, signal=118%</td></tr><tr><td class='lessen'>146</td><td>ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP</td><td></td><td>127</td><td>0.32</td><td>1.83</td><td>0.000</td><td>0.025</td><td>0.947</td><td>236</td><td>tags=31%, list=19%, signal=34%</td></tr><tr><td class='lessen'>147</td><td>UDAYAKUMAR_MED1_TARGETS_UP</td><td></td><td>24</td><td>0.46</td><td>1.82</td><td>0.008</td><td>0.029</td><td>0.966</td><td>401</td><td>tags=67%, list=32%, signal=96%</td></tr><tr><td class='lessen'>148</td><td>FOURNIER_ACINAR_DEVELOPMENT_LATE_2</td><td></td><td>60</td><td>0.37</td><td>1.81</td><td>0.002</td><td>0.029</td><td>0.969</td><td>575</td><td>tags=77%, list=45%, signal=133%</td></tr><tr><td class='lessen'>149</td><td>PAL_PRMT5_TARGETS_UP</td><td></td><td>46</td><td>0.39</td><td>1.81</td><td>0.000</td><td>0.029</td><td>0.969</td><td>466</td><td>tags=65%, list=37%, signal=99%</td></tr><tr><td class='lessen'>150</td><td>GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN</td><td></td><td>22</td><td>0.47</td><td>1.81</td><td>0.002</td><td>0.030</td><td>0.977</td><td>79</td><td>tags=23%, list=6%, signal=24%</td></tr><tr><td class='lessen'>151</td><td>MCBRYAN_PUBERTAL_BREAST_3_4WK_UP</td><td></td><td>42</td><td>0.40</td><td>1.81</td><td>0.002</td><td>0.030</td><td>0.977</td><td>388</td><td>tags=52%, list=31%, signal=73%</td></tr><tr><td class='lessen'>152</td><td>LUI_THYROID_CANCER_PAX8_PPARG_DN</td><td></td><td>26</td><td>0.46</td><td>1.81</td><td>0.007</td><td>0.030</td><td>0.977</td><td>200</td><td>tags=50%, list=16%, signal=58%</td></tr><tr><td class='lessen'>153</td><td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM</td><td></td><td>24</td><td>0.45</td><td>1.78</td><td>0.002</td><td>0.037</td><td>0.986</td><td>406</td><td>tags=63%, list=32%, signal=90%</td></tr><tr><td class='lessen'>154</td><td>MARSON_BOUND_BY_E2F4_UNSTIMULATED</td><td></td><td>65</td><td>0.35</td><td>1.77</td><td>0.000</td><td>0.038</td><td>0.987</td><td>598</td><td>tags=75%, list=47%, signal=135%</td></tr><tr><td class='lessen'>155</td><td>GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN</td><td></td><td>171</td><td>0.29</td><td>1.77</td><td>0.003</td><td>0.039</td><td>0.990</td><td>732</td><td>tags=82%, list=58%, signal=168%</td></tr><tr><td class='lessen'>156</td><td>REACTOME_CHROMOSOME_MAINTENANCE</td><td></td><td>16</td><td>0.51</td><td>1.77</td><td>0.006</td><td>0.039</td><td>0.990</td><td>633</td><td>tags=100%, list=50%, signal=197%</td></tr><tr><td class='lessen'>157</td><td>SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP</td><td></td><td>18</td><td>0.49</td><td>1.76</td><td>0.016</td><td>0.040</td><td>0.991</td><td>249</td><td>tags=50%, list=20%, signal=61%</td></tr><tr><td class='lessen'>158</td><td>GNATENKO_PLATELET_SIGNATURE</td><td></td><td>15</td><td>0.52</td><td>1.76</td><td>0.014</td><td>0.040</td><td>0.991</td><td>110</td><td>tags=40%, list=9%, signal=43%</td></tr><tr><td class='lessen'>159</td><td>SANA_TNF_SIGNALING_DN</td><td></td><td>17</td><td>0.49</td><td>1.76</td><td>0.010</td><td>0.040</td><td>0.992</td><td>222</td><td>tags=47%, list=17%, signal=56%</td></tr><tr><td class='lessen'>160</td><td>REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION</td><td></td><td>18</td><td>0.49</td><td>1.75</td><td>0.011</td><td>0.045</td><td>0.995</td><td>449</td><td>tags=72%, list=35%, signal=110%</td></tr><tr><td class='lessen'>161</td><td>BENPORATH_PROLIFERATION</td><td></td><td>26</td><td>0.44</td><td>1.74</td><td>0.011</td><td>0.047</td><td>0.995</td><td>665</td><td>tags=96%, list=52%, signal=198%</td></tr><tr><td class='lessen'>162</td><td>DAZARD_RESPONSE_TO_UV_NHEK_UP</td><td></td><td>58</td><td>0.35</td><td>1.74</td><td>0.007</td><td>0.047</td><td>0.995</td><td>145</td><td>tags=31%, list=11%, signal=33%</td></tr><tr><td class='lessen'>163</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP</td><td></td><td>36</td><td>0.40</td><td>1.74</td><td>0.004</td><td>0.047</td><td>0.996</td><td>379</td><td>tags=53%, list=30%, signal=73%</td></tr><tr><td class='lessen'>164</td><td>LE_EGR2_TARGETS_UP</td><td></td><td>27</td><td>0.43</td><td>1.73</td><td>0.018</td><td>0.048</td><td>0.996</td><td>304</td><td>tags=52%, list=24%, signal=67%</td></tr><tr><td class='lessen'>165</td><td>HOEBEKE_LYMPHOID_STEM_CELL_DN</td><td></td><td>22</td><td>0.45</td><td>1.73</td><td>0.017</td><td>0.048</td><td>0.996</td><td>242</td><td>tags=45%, list=19%, signal=55%</td></tr><tr><td class='lessen'>166</td><td>GERHOLD_ADIPOGENESIS_DN</td><td></td><td>24</td><td>0.44</td><td>1.73</td><td>0.009</td><td>0.049</td><td>0.996</td><td>524</td><td>tags=79%, list=41%, signal=132%</td></tr><tr><td class='lessen'>167</td><td>MARTINEZ_RB1_TARGETS_DN</td><td></td><td>91</td><td>0.32</td><td>1.72</td><td>0.000</td><td>0.050</td><td>0.996</td><td>247</td><td>tags=32%, list=19%, signal=37%</td></tr><tr><td class='lessen'>168</td><td>SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN</td><td></td><td>20</td><td>0.46</td><td>1.71</td><td>0.009</td><td>0.055</td><td>0.999</td><td>451</td><td>tags=70%, list=35%, signal=107%</td></tr><tr><td class='lessen'>169</td><td>BRUECKNER_TARGETS_OF_MIRLET7A3_DN</td><td></td><td>16</td><td>0.49</td><td>1.71</td><td>0.012</td><td>0.055</td><td>0.999</td><td>271</td><td>tags=56%, list=21%, signal=71%</td></tr><tr><td class='lessen'>170</td><td>KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP</td><td></td><td>152</td><td>0.29</td><td>1.71</td><td>0.000</td><td>0.055</td><td>0.999</td><td>631</td><td>tags=73%, list=50%, signal=128%</td></tr><tr><td class='lessen'>171</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1</td><td></td><td>63</td><td>0.34</td><td>1.71</td><td>0.000</td><td>0.055</td><td>0.999</td><td>567</td><td>tags=73%, list=45%, signal=125%</td></tr><tr><td class='lessen'>172</td><td>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP</td><td></td><td>32</td><td>0.40</td><td>1.70</td><td>0.010</td><td>0.057</td><td>1.000</td><td>665</td><td>tags=91%, list=52%, signal=185%</td></tr><tr><td class='lessen'>173</td><td>LEE_LIVER_CANCER_MYC_TGFA_UP</td><td></td><td>15</td><td>0.51</td><td>1.70</td><td>0.022</td><td>0.058</td><td>1.000</td><td>416</td><td>tags=80%, list=33%, signal=118%</td></tr><tr><td class='lessen'>174</td><td>MILI_PSEUDOPODIA_HAPTOTAXIS_UP</td><td></td><td>62</td><td>0.33</td><td>1.69</td><td>0.007</td><td>0.059</td><td>1.000</td><td>659</td><td>tags=82%, list=52%, signal=162%</td></tr><tr><td class='lessen'>175</td><td>GRESHOCK_CANCER_COPY_NUMBER_UP</td><td></td><td>32</td><td>0.39</td><td>1.69</td><td>0.018</td><td>0.060</td><td>1.000</td><td>289</td><td>tags=47%, list=23%, signal=59%</td></tr><tr><td class='lessen'>176</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN</td><td></td><td>30</td><td>0.40</td><td>1.69</td><td>0.009</td><td>0.061</td><td>1.000</td><td>465</td><td>tags=67%, list=37%, signal=103%</td></tr><tr><td class='lessen'>177</td><td>WHITFIELD_CELL_CYCLE_M_G1</td><td></td><td>18</td><td>0.47</td><td>1.69</td><td>0.015</td><td>0.062</td><td>1.000</td><td>328</td><td>tags=61%, list=26%, signal=81%</td></tr><tr><td class='lessen'>178</td><td>FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN</td><td></td><td>22</td><td>0.43</td><td>1.68</td><td>0.021</td><td>0.063</td><td>1.000</td><td>435</td><td>tags=68%, list=34%, signal=102%</td></tr><tr><td class='lessen'>179</td><td>REACTOME_SELECTIVE_AUTOPHAGY</td><td></td><td>21</td><td>0.44</td><td>1.68</td><td>0.023</td><td>0.063</td><td>1.000</td><td>506</td><td>tags=81%, list=40%, signal=132%</td></tr><tr><td class='lessen'>180</td><td>VECCHI_GASTRIC_CANCER_EARLY_UP</td><td></td><td>80</td><td>0.32</td><td>1.68</td><td>0.005</td><td>0.063</td><td>1.000</td><td>259</td><td>tags=31%, list=20%, signal=37%</td></tr><tr><td class='lessen'>181</td><td>WHITEFORD_PEDIATRIC_CANCER_MARKERS</td><td></td><td>20</td><td>0.45</td><td>1.68</td><td>0.018</td><td>0.064</td><td>1.000</td><td>665</td><td>tags=95%, list=52%, signal=196%</td></tr><tr><td class='lessen'>182</td><td>REACTOME_M_PHASE</td><td></td><td>43</td><td>0.35</td><td>1.67</td><td>0.012</td><td>0.069</td><td>1.000</td><td>571</td><td>tags=70%, list=45%, signal=122%</td></tr><tr><td class='lessen'>183</td><td>WINNEPENNINCKX_MELANOMA_METASTASIS_UP</td><td></td><td>24</td><td>0.42</td><td>1.67</td><td>0.023</td><td>0.068</td><td>1.000</td><td>684</td><td>tags=96%, list=54%, signal=204%</td></tr><tr><td class='lessen'>184</td><td>REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION</td><td></td><td>18</td><td>0.46</td><td>1.66</td><td>0.024</td><td>0.069</td><td>1.000</td><td>459</td><td>tags=72%, list=36%, signal=111%</td></tr><tr><td class='lessen'>185</td><td>RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP</td><td></td><td>16</td><td>0.48</td><td>1.66</td><td>0.031</td><td>0.071</td><td>1.000</td><td>352</td><td>tags=56%, list=28%, signal=77%</td></tr><tr><td class='lessen'>186</td><td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP</td><td></td><td>30</td><td>0.40</td><td>1.65</td><td>0.013</td><td>0.075</td><td>1.000</td><td>144</td><td>tags=33%, list=11%, signal=37%</td></tr><tr><td class='lessen'>187</td><td>CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN</td><td></td><td>38</td><td>0.37</td><td>1.65</td><td>0.007</td><td>0.075</td><td>1.000</td><td>271</td><td>tags=45%, list=21%, signal=55%</td></tr><tr><td class='lessen'>188</td><td>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR</td><td></td><td>16</td><td>0.47</td><td>1.65</td><td>0.024</td><td>0.074</td><td>1.000</td><td>571</td><td>tags=88%, list=45%, signal=157%</td></tr><tr><td class='lessen'>189</td><td>SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6</td><td></td><td>58</td><td>0.33</td><td>1.65</td><td>0.011</td><td>0.075</td><td>1.000</td><td>525</td><td>tags=66%, list=41%, signal=107%</td></tr><tr><td class='lessen'>190</td><td>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN</td><td></td><td>108</td><td>0.29</td><td>1.65</td><td>0.005</td><td>0.075</td><td>1.000</td><td>300</td><td>tags=37%, list=24%, signal=44%</td></tr><tr><td class='lessen'>191</td><td>REACTOME_AUTOPHAGY</td><td></td><td>27</td><td>0.41</td><td>1.64</td><td>0.021</td><td>0.077</td><td>1.000</td><td>356</td><td>tags=56%, list=28%, signal=76%</td></tr><tr><td class='lessen'>192</td><td>BENPORATH_OCT4_TARGETS</td><td></td><td>23</td><td>0.43</td><td>1.64</td><td>0.019</td><td>0.077</td><td>1.000</td><td>591</td><td>tags=83%, list=46%, signal=152%</td></tr><tr><td class='lessen'>193</td><td>RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN</td><td></td><td>102</td><td>0.30</td><td>1.64</td><td>0.007</td><td>0.079</td><td>1.000</td><td>346</td><td>tags=45%, list=27%, signal=57%</td></tr><tr><td class='lessen'>194</td><td>GOLDRATH_HOMEOSTATIC_PROLIFERATION</td><td></td><td>30</td><td>0.40</td><td>1.64</td><td>0.032</td><td>0.078</td><td>1.000</td><td>247</td><td>tags=40%, list=19%, signal=48%</td></tr><tr><td class='lessen'>195</td><td>ZHANG_BREAST_CANCER_PROGENITORS_UP</td><td></td><td>65</td><td>0.32</td><td>1.63</td><td>0.007</td><td>0.080</td><td>1.000</td><td>665</td><td>tags=83%, list=52%, signal=165%</td></tr><tr><td class='lessen'>196</td><td>TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C</td><td></td><td>46</td><td>0.35</td><td>1.63</td><td>0.017</td><td>0.082</td><td>1.000</td><td>522</td><td>tags=67%, list=41%, signal=110%</td></tr><tr><td class='lessen'>197</td><td>BURTON_ADIPOGENESIS_7</td><td></td><td>20</td><td>0.44</td><td>1.61</td><td>0.038</td><td>0.089</td><td>1.000</td><td>237</td><td>tags=45%, list=19%, signal=54%</td></tr><tr><td class='lessen'>198</td><td>WEI_MYCN_TARGETS_WITH_E_BOX</td><td></td><td>110</td><td>0.29</td><td>1.61</td><td>0.012</td><td>0.090</td><td>1.000</td><td>575</td><td>tags=70%, list=45%, signal=117%</td></tr><tr><td class='lessen'>199</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP</td><td></td><td>17</td><td>0.45</td><td>1.61</td><td>0.045</td><td>0.090</td><td>1.000</td><td>273</td><td>tags=53%, list=21%, signal=67%</td></tr><tr><td class='lessen'>200</td><td>MCBRYAN_PUBERTAL_BREAST_4_5WK_UP</td><td></td><td>73</td><td>0.31</td><td>1.61</td><td>0.009</td><td>0.090</td><td>1.000</td><td>229</td><td>tags=30%, list=18%, signal=35%</td></tr><tr><td class='lessen'>201</td><td>LEI_MYB_TARGETS</td><td></td><td>70</td><td>0.31</td><td>1.60</td><td>0.009</td><td>0.093</td><td>1.000</td><td>300</td><td>tags=40%, list=24%, signal=49%</td></tr><tr><td class='lessen'>202</td><td>RUIZ_TNC_TARGETS_DN</td><td></td><td>22</td><td>0.41</td><td>1.60</td><td>0.042</td><td>0.094</td><td>1.000</td><td>665</td><td>tags=91%, list=52%, signal=187%</td></tr><tr><td class='lessen'>203</td><td>DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP</td><td></td><td>217</td><td>0.25</td><td>1.60</td><td>0.000</td><td>0.096</td><td>1.000</td><td>656</td><td>tags=72%, list=52%, signal=123%</td></tr><tr><td class='lessen'>204</td><td>WU_CELL_MIGRATION</td><td></td><td>40</td><td>0.35</td><td>1.60</td><td>0.020</td><td>0.096</td><td>1.000</td><td>381</td><td>tags=52%, list=30%, signal=73%</td></tr><tr><td class='lessen'>205</td><td>PUJANA_BRCA2_PCC_NETWORK</td><td></td><td>45</td><td>0.35</td><td>1.59</td><td>0.026</td><td>0.102</td><td>1.000</td><td>684</td><td>tags=91%, list=54%, signal=190%</td></tr><tr><td class='lessen'>206</td><td>SANSOM_APC_TARGETS</td><td></td><td>17</td><td>0.45</td><td>1.58</td><td>0.044</td><td>0.103</td><td>1.000</td><td>512</td><td>tags=82%, list=40%, signal=136%</td></tr><tr><td class='lessen'>207</td><td>PATIL_LIVER_CANCER</td><td></td><td>80</td><td>0.30</td><td>1.58</td><td>0.012</td><td>0.103</td><td>1.000</td><td>291</td><td>tags=35%, list=23%, signal=43%</td></tr><tr><td class='lessen'>208</td><td>BLUM_RESPONSE_TO_SALIRASIB_DN</td><td></td><td>69</td><td>0.31</td><td>1.58</td><td>0.024</td><td>0.104</td><td>1.000</td><td>470</td><td>tags=61%, list=37%, signal=91%</td></tr><tr><td class='lessen'>209</td><td>REACTOME_CELL_CYCLE_MITOTIC</td><td></td><td>59</td><td>0.32</td><td>1.58</td><td>0.017</td><td>0.105</td><td>1.000</td><td>525</td><td>tags=61%, list=41%, signal=99%</td></tr><tr><td class='lessen'>210</td><td>MITSIADES_RESPONSE_TO_APLIDIN_DN</td><td></td><td>49</td><td>0.34</td><td>1.57</td><td>0.011</td><td>0.106</td><td>1.000</td><td>742</td><td>tags=92%, list=58%, signal=212%</td></tr><tr><td class='lessen'>211</td><td>HELLER_HDAC_TARGETS_DN</td><td></td><td>42</td><td>0.35</td><td>1.56</td><td>0.033</td><td>0.113</td><td>1.000</td><td>400</td><td>tags=55%, list=31%, signal=77%</td></tr><tr><td class='lessen'>212</td><td>SWEET_LUNG_CANCER_KRAS_UP</td><td></td><td>133</td><td>0.27</td><td>1.56</td><td>0.000</td><td>0.113</td><td>1.000</td><td>343</td><td>tags=40%, list=27%, signal=49%</td></tr><tr><td class='lessen'>213</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12</td><td></td><td>15</td><td>0.46</td><td>1.56</td><td>0.048</td><td>0.114</td><td>1.000</td><td>487</td><td>tags=73%, list=38%, signal=117%</td></tr><tr><td class='lessen'>214</td><td>ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP</td><td></td><td>30</td><td>0.37</td><td>1.56</td><td>0.035</td><td>0.116</td><td>1.000</td><td>180</td><td>tags=40%, list=14%, signal=45%</td></tr><tr><td class='lessen'>215</td><td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE</td><td></td><td>24</td><td>0.39</td><td>1.55</td><td>0.046</td><td>0.119</td><td>1.000</td><td>125</td><td>tags=25%, list=10%, signal=27%</td></tr><tr><td class='lessen'>216</td><td>MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP</td><td></td><td>34</td><td>0.36</td><td>1.55</td><td>0.045</td><td>0.119</td><td>1.000</td><td>260</td><td>tags=35%, list=20%, signal=43%</td></tr><tr><td class='lessen'>217</td><td>KAUFFMANN_DNA_REPLICATION_GENES</td><td></td><td>16</td><td>0.44</td><td>1.55</td><td>0.036</td><td>0.119</td><td>1.000</td><td>676</td><td>tags=94%, list=53%, signal=198%</td></tr><tr><td class='lessen'>218</td><td>GROSS_HYPOXIA_VIA_HIF1A_UP</td><td></td><td>20</td><td>0.42</td><td>1.55</td><td>0.043</td><td>0.119</td><td>1.000</td><td>464</td><td>tags=75%, list=37%, signal=116%</td></tr><tr><td class='lessen'>219</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP</td><td></td><td>32</td><td>0.36</td><td>1.54</td><td>0.048</td><td>0.122</td><td>1.000</td><td>614</td><td>tags=84%, list=48%, signal=159%</td></tr><tr><td class='lessen'>220</td><td>DANG_REGULATED_BY_MYC_UP</td><td></td><td>17</td><td>0.44</td><td>1.54</td><td>0.049</td><td>0.124</td><td>1.000</td><td>447</td><td>tags=71%, list=35%, signal=107%</td></tr><tr><td class='lessen'>221</td><td>IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR</td><td></td><td>28</td><td>0.38</td><td>1.54</td><td>0.043</td><td>0.124</td><td>1.000</td><td>171</td><td>tags=29%, list=13%, signal=32%</td></tr><tr><td class='lessen'>222</td><td>KIM_ALL_DISORDERS_DURATION_CORR_DN</td><td></td><td>26</td><td>0.38</td><td>1.54</td><td>0.050</td><td>0.124</td><td>1.000</td><td>72</td><td>tags=19%, list=6%, signal=20%</td></tr><tr><td class='lessen'>223</td><td>ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER</td><td></td><td>21</td><td>0.41</td><td>1.54</td><td>0.052</td><td>0.123</td><td>1.000</td><td>665</td><td>tags=90%, list=52%, signal=187%</td></tr><tr><td class='lessen'>224</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN</td><td></td><td>80</td><td>0.29</td><td>1.54</td><td>0.014</td><td>0.125</td><td>1.000</td><td>609</td><td>tags=76%, list=48%, signal=137%</td></tr><tr><td class='lessen'>225</td><td>DARWICHE_SKIN_TUMOR_PROMOTER_DN</td><td></td><td>24</td><td>0.40</td><td>1.53</td><td>0.059</td><td>0.128</td><td>1.000</td><td>138</td><td>tags=29%, list=11%, signal=32%</td></tr><tr><td class='lessen'>226</td><td>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN</td><td></td><td>35</td><td>0.35</td><td>1.53</td><td>0.055</td><td>0.129</td><td>1.000</td><td>515</td><td>tags=69%, list=41%, signal=112%</td></tr><tr><td class='lessen'>227</td><td>REACTOME_DNA_REPAIR</td><td></td><td>22</td><td>0.39</td><td>1.52</td><td>0.045</td><td>0.139</td><td>1.000</td><td>457</td><td>tags=64%, list=36%, signal=98%</td></tr><tr><td class='lessen'>228</td><td>ENK_UV_RESPONSE_KERATINOCYTE_UP</td><td></td><td>118</td><td>0.27</td><td>1.51</td><td>0.010</td><td>0.140</td><td>1.000</td><td>133</td><td>tags=23%, list=10%, signal=23%</td></tr><tr><td class='lessen'>229</td><td>APPIERTO_RESPONSE_TO_FENRETINIDE_DN</td><td></td><td>15</td><td>0.45</td><td>1.51</td><td>0.046</td><td>0.142</td><td>1.000</td><td>81</td><td>tags=27%, list=6%, signal=28%</td></tr><tr><td class='lessen'>230</td><td>SASAKI_ADULT_T_CELL_LEUKEMIA</td><td></td><td>23</td><td>0.38</td><td>1.51</td><td>0.061</td><td>0.142</td><td>1.000</td><td>435</td><td>tags=65%, list=34%, signal=97%</td></tr><tr><td class='lessen'>231</td><td>BASSO_B_LYMPHOCYTE_NETWORK</td><td></td><td>34</td><td>0.34</td><td>1.51</td><td>0.054</td><td>0.145</td><td>1.000</td><td>144</td><td>tags=26%, list=11%, signal=29%</td></tr><tr><td class='lessen'>232</td><td>RATTENBACHER_BOUND_BY_CELF1</td><td></td><td>26</td><td>0.39</td><td>1.50</td><td>0.064</td><td>0.150</td><td>1.000</td><td>222</td><td>tags=38%, list=17%, signal=46%</td></tr><tr><td class='lessen'>233</td><td>OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN</td><td></td><td>33</td><td>0.35</td><td>1.50</td><td>0.056</td><td>0.153</td><td>1.000</td><td>339</td><td>tags=45%, list=27%, signal=60%</td></tr><tr><td class='lessen'>234</td><td>LEE_LIVER_CANCER_DENA_UP</td><td></td><td>15</td><td>0.45</td><td>1.49</td><td>0.073</td><td>0.155</td><td>1.000</td><td>323</td><td>tags=53%, list=25%, signal=71%</td></tr><tr><td class='lessen'>235</td><td>REACTOME_HIV_LIFE_CYCLE</td><td></td><td>18</td><td>0.41</td><td>1.48</td><td>0.078</td><td>0.163</td><td>1.000</td><td>390</td><td>tags=56%, list=31%, signal=79%</td></tr><tr><td class='lessen'>236</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN</td><td></td><td>79</td><td>0.28</td><td>1.48</td><td>0.017</td><td>0.163</td><td>1.000</td><td>593</td><td>tags=67%, list=47%, signal=118%</td></tr><tr><td class='lessen'>237</td><td>PUJANA_BRCA_CENTERED_NETWORK</td><td></td><td>17</td><td>0.42</td><td>1.48</td><td>0.070</td><td>0.163</td><td>1.000</td><td>633</td><td>tags=88%, list=50%, signal=173%</td></tr><tr><td class='lessen'>238</td><td>GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN</td><td></td><td>25</td><td>0.37</td><td>1.48</td><td>0.066</td><td>0.163</td><td>1.000</td><td>593</td><td>tags=80%, list=47%, signal=147%</td></tr><tr><td class='lessen'>239</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP</td><td></td><td>32</td><td>0.34</td><td>1.48</td><td>0.072</td><td>0.164</td><td>1.000</td><td>453</td><td>tags=59%, list=36%, signal=90%</td></tr><tr><td class='lessen'>240</td><td>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP</td><td></td><td>34</td><td>0.34</td><td>1.48</td><td>0.071</td><td>0.165</td><td>1.000</td><td>260</td><td>tags=35%, list=20%, signal=43%</td></tr><tr><td class='lessen'>241</td><td>REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE</td><td></td><td>27</td><td>0.37</td><td>1.47</td><td>0.076</td><td>0.166</td><td>1.000</td><td>404</td><td>tags=59%, list=32%, signal=85%</td></tr><tr><td class='lessen'>242</td><td>MULLIGHAN_MLL_SIGNATURE_1_DN</td><td></td><td>19</td><td>0.40</td><td>1.47</td><td>0.078</td><td>0.169</td><td>1.000</td><td>132</td><td>tags=32%, list=10%, signal=35%</td></tr><tr><td class='lessen'>243</td><td>MCBRYAN_PUBERTAL_BREAST_6_7WK_DN</td><td></td><td>17</td><td>0.41</td><td>1.46</td><td>0.085</td><td>0.174</td><td>1.000</td><td>403</td><td>tags=59%, list=32%, signal=85%</td></tr><tr><td class='lessen'>244</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP</td><td></td><td>33</td><td>0.34</td><td>1.46</td><td>0.059</td><td>0.174</td><td>1.000</td><td>311</td><td>tags=42%, list=24%, signal=55%</td></tr><tr><td class='lessen'>245</td><td>MOHANKUMAR_HOXA1_TARGETS_DN</td><td></td><td>20</td><td>0.39</td><td>1.46</td><td>0.077</td><td>0.176</td><td>1.000</td><td>153</td><td>tags=35%, list=12%, signal=39%</td></tr><tr><td class='lessen'>246</td><td>GOLDRATH_ANTIGEN_RESPONSE</td><td></td><td>67</td><td>0.28</td><td>1.45</td><td>0.027</td><td>0.181</td><td>1.000</td><td>275</td><td>tags=31%, list=22%, signal=38%</td></tr><tr><td class='lessen'>247</td><td>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN</td><td></td><td>46</td><td>0.32</td><td>1.45</td><td>0.059</td><td>0.183</td><td>1.000</td><td>285</td><td>tags=41%, list=22%, signal=51%</td></tr><tr><td class='lessen'>248</td><td>RICKMAN_METASTASIS_DN</td><td></td><td>35</td><td>0.33</td><td>1.45</td><td>0.067</td><td>0.184</td><td>1.000</td><td>212</td><td>tags=31%, list=17%, signal=37%</td></tr><tr><td class='lessen'>249</td><td>BURTON_ADIPOGENESIS_3</td><td></td><td>19</td><td>0.40</td><td>1.45</td><td>0.084</td><td>0.185</td><td>1.000</td><td>665</td><td>tags=89%, list=52%, signal=185%</td></tr><tr><td class='lessen'>250</td><td>JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN</td><td></td><td>50</td><td>0.31</td><td>1.44</td><td>0.041</td><td>0.189</td><td>1.000</td><td>336</td><td>tags=48%, list=26%, signal=63%</td></tr><tr><td class='lessen'>251</td><td>REACTOME_MITOTIC_PROMETAPHASE</td><td></td><td>15</td><td>0.44</td><td>1.44</td><td>0.087</td><td>0.190</td><td>1.000</td><td>502</td><td>tags=73%, list=39%, signal=120%</td></tr><tr><td class='lessen'>252</td><td>BILANGES_SERUM_SENSITIVE_GENES</td><td></td><td>20</td><td>0.39</td><td>1.44</td><td>0.086</td><td>0.190</td><td>1.000</td><td>89</td><td>tags=25%, list=7%, signal=26%</td></tr><tr><td class='lessen'>253</td><td>PROVENZANI_METASTASIS_DN</td><td></td><td>23</td><td>0.37</td><td>1.44</td><td>0.080</td><td>0.192</td><td>1.000</td><td>293</td><td>tags=39%, list=23%, signal=50%</td></tr><tr><td class='lessen'>254</td><td>NABA_SECRETED_FACTORS</td><td></td><td>16</td><td>0.42</td><td>1.44</td><td>0.093</td><td>0.193</td><td>1.000</td><td>245</td><td>tags=44%, list=19%, signal=54%</td></tr><tr><td class='lessen'>255</td><td>ONDER_CDH1_TARGETS_1_DN</td><td></td><td>29</td><td>0.35</td><td>1.43</td><td>0.079</td><td>0.198</td><td>1.000</td><td>503</td><td>tags=69%, list=40%, signal=112%</td></tr><tr><td class='lessen'>256</td><td>DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP</td><td></td><td>61</td><td>0.29</td><td>1.43</td><td>0.049</td><td>0.200</td><td>1.000</td><td>235</td><td>tags=31%, list=18%, signal=36%</td></tr><tr><td class='lessen'>257</td><td>XU_GH1_AUTOCRINE_TARGETS_DN</td><td></td><td>18</td><td>0.40</td><td>1.42</td><td>0.100</td><td>0.205</td><td>1.000</td><td>512</td><td>tags=83%, list=40%, signal=138%</td></tr><tr><td class='lessen'>258</td><td>LIU_PROSTATE_CANCER_UP</td><td></td><td>15</td><td>0.43</td><td>1.42</td><td>0.095</td><td>0.208</td><td>1.000</td><td>351</td><td>tags=60%, list=28%, signal=82%</td></tr><tr><td class='lessen'>259</td><td>MATTIOLI_MGUS_VS_PCL</td><td></td><td>25</td><td>0.36</td><td>1.42</td><td>0.099</td><td>0.209</td><td>1.000</td><td>298</td><td>tags=48%, list=23%, signal=61%</td></tr><tr><td class='lessen'>260</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17</td><td></td><td>42</td><td>0.31</td><td>1.42</td><td>0.061</td><td>0.209</td><td>1.000</td><td>567</td><td>tags=69%, list=45%, signal=121%</td></tr><tr><td class='lessen'>261</td><td>BENPORATH_NANOG_TARGETS</td><td></td><td>100</td><td>0.26</td><td>1.42</td><td>0.036</td><td>0.208</td><td>1.000</td><td>206</td><td>tags=25%, list=16%, signal=27%</td></tr><tr><td class='lessen'>262</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP</td><td></td><td>49</td><td>0.30</td><td>1.41</td><td>0.076</td><td>0.211</td><td>1.000</td><td>569</td><td>tags=69%, list=45%, signal=121%</td></tr><tr><td class='lessen'>263</td><td>KAAB_HEART_ATRIUM_VS_VENTRICLE_UP</td><td></td><td>29</td><td>0.35</td><td>1.41</td><td>0.072</td><td>0.213</td><td>1.000</td><td>190</td><td>tags=31%, list=15%, signal=36%</td></tr><tr><td class='lessen'>264</td><td>HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>34</td><td>0.33</td><td>1.41</td><td>0.093</td><td>0.214</td><td>1.000</td><td>711</td><td>tags=88%, list=56%, signal=195%</td></tr><tr><td class='lessen'>265</td><td>VANTVEER_BREAST_CANCER_ESR1_DN</td><td></td><td>30</td><td>0.33</td><td>1.40</td><td>0.090</td><td>0.221</td><td>1.000</td><td>439</td><td>tags=57%, list=35%, signal=85%</td></tr><tr><td class='lessen'>266</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP</td><td></td><td>22</td><td>0.37</td><td>1.40</td><td>0.105</td><td>0.222</td><td>1.000</td><td>97</td><td>tags=23%, list=8%, signal=24%</td></tr><tr><td class='lessen'>267</td><td>BOYLAN_MULTIPLE_MYELOMA_C_D_UP</td><td></td><td>22</td><td>0.37</td><td>1.39</td><td>0.122</td><td>0.231</td><td>1.000</td><td>462</td><td>tags=64%, list=36%, signal=98%</td></tr><tr><td class='lessen'>268</td><td>BROWN_MYELOID_CELL_DEVELOPMENT_DN</td><td></td><td>32</td><td>0.32</td><td>1.39</td><td>0.080</td><td>0.231</td><td>1.000</td><td>472</td><td>tags=59%, list=37%, signal=92%</td></tr><tr><td class='lessen'>269</td><td>MORI_SMALL_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>16</td><td>0.41</td><td>1.39</td><td>0.115</td><td>0.236</td><td>1.000</td><td>230</td><td>tags=44%, list=18%, signal=53%</td></tr><tr><td class='lessen'>270</td><td>REACTOME_CHROMATIN_MODIFYING_ENZYMES</td><td></td><td>15</td><td>0.41</td><td>1.38</td><td>0.114</td><td>0.241</td><td>1.000</td><td>651</td><td>tags=87%, list=51%, signal=176%</td></tr><tr><td class='lessen'>271</td><td>GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP</td><td></td><td>58</td><td>0.28</td><td>1.38</td><td>0.085</td><td>0.249</td><td>1.000</td><td>665</td><td>tags=79%, list=52%, signal=159%</td></tr><tr><td class='lessen'>272</td><td>CHANDRAN_METASTASIS_TOP50_UP</td><td></td><td>15</td><td>0.40</td><td>1.37</td><td>0.127</td><td>0.250</td><td>1.000</td><td>558</td><td>tags=80%, list=44%, signal=141%</td></tr><tr><td class='lessen'>273</td><td>WOO_LIVER_CANCER_RECURRENCE_UP</td><td></td><td>16</td><td>0.40</td><td>1.37</td><td>0.118</td><td>0.251</td><td>1.000</td><td>304</td><td>tags=50%, list=24%, signal=65%</td></tr><tr><td class='lessen'>274</td><td>HOLLMANN_APOPTOSIS_VIA_CD40_DN</td><td></td><td>32</td><td>0.32</td><td>1.37</td><td>0.084</td><td>0.256</td><td>1.000</td><td>420</td><td>tags=53%, list=33%, signal=77%</td></tr><tr><td class='lessen'>275</td><td>GRUETZMANN_PANCREATIC_CANCER_UP</td><td></td><td>71</td><td>0.26</td><td>1.37</td><td>0.051</td><td>0.256</td><td>1.000</td><td>387</td><td>tags=45%, list=30%, signal=61%</td></tr><tr><td class='lessen'>276</td><td>LU_EZH2_TARGETS_UP</td><td></td><td>34</td><td>0.31</td><td>1.36</td><td>0.104</td><td>0.267</td><td>1.000</td><td>413</td><td>tags=50%, list=32%, signal=72%</td></tr><tr><td class='lessen'>277</td><td>KIM_WT1_TARGETS_12HR_DN</td><td></td><td>39</td><td>0.30</td><td>1.35</td><td>0.104</td><td>0.269</td><td>1.000</td><td>339</td><td>tags=41%, list=27%, signal=54%</td></tr><tr><td class='lessen'>278</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP</td><td></td><td>36</td><td>0.31</td><td>1.35</td><td>0.104</td><td>0.272</td><td>1.000</td><td>310</td><td>tags=44%, list=24%, signal=57%</td></tr><tr><td class='lessen'>279</td><td>GARY_CD5_TARGETS_DN</td><td></td><td>63</td><td>0.27</td><td>1.35</td><td>0.059</td><td>0.273</td><td>1.000</td><td>724</td><td>tags=86%, list=57%, signal=189%</td></tr><tr><td class='lessen'>280</td><td>DIRMEIER_LMP1_RESPONSE_EARLY</td><td></td><td>18</td><td>0.38</td><td>1.35</td><td>0.112</td><td>0.273</td><td>1.000</td><td>105</td><td>tags=28%, list=8%, signal=30%</td></tr><tr><td class='lessen'>281</td><td>SENESE_HDAC2_TARGETS_UP</td><td></td><td>15</td><td>0.39</td><td>1.35</td><td>0.147</td><td>0.274</td><td>1.000</td><td>394</td><td>tags=53%, list=31%, signal=76%</td></tr><tr><td class='lessen'>282</td><td>MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP</td><td></td><td>37</td><td>0.30</td><td>1.35</td><td>0.120</td><td>0.274</td><td>1.000</td><td>326</td><td>tags=38%, list=26%, signal=49%</td></tr><tr><td class='lessen'>283</td><td>IGLESIAS_E2F_TARGETS_UP</td><td></td><td>36</td><td>0.32</td><td>1.34</td><td>0.121</td><td>0.276</td><td>1.000</td><td>161</td><td>tags=28%, list=13%, signal=31%</td></tr><tr><td class='lessen'>284</td><td>SESTO_RESPONSE_TO_UV_C0</td><td></td><td>23</td><td>0.35</td><td>1.34</td><td>0.131</td><td>0.276</td><td>1.000</td><td>310</td><td>tags=48%, list=24%, signal=62%</td></tr><tr><td class='lessen'>285</td><td>HUMMERICH_SKIN_CANCER_PROGRESSION_UP</td><td></td><td>21</td><td>0.36</td><td>1.33</td><td>0.132</td><td>0.290</td><td>1.000</td><td>164</td><td>tags=29%, list=13%, signal=32%</td></tr><tr><td class='lessen'>286</td><td>KAUFFMANN_DNA_REPAIR_GENES</td><td></td><td>16</td><td>0.39</td><td>1.33</td><td>0.156</td><td>0.298</td><td>1.000</td><td>614</td><td>tags=88%, list=48%, signal=167%</td></tr><tr><td class='lessen'>287</td><td>TIEN_INTESTINE_PROBIOTICS_24HR_UP</td><td></td><td>112</td><td>0.24</td><td>1.32</td><td>0.087</td><td>0.301</td><td>1.000</td><td>470</td><td>tags=54%, list=37%, signal=79%</td></tr><tr><td class='lessen'>288</td><td>LEE_RECENT_THYMIC_EMIGRANT</td><td></td><td>33</td><td>0.31</td><td>1.32</td><td>0.122</td><td>0.300</td><td>1.000</td><td>186</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>289</td><td>OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP</td><td></td><td>32</td><td>0.30</td><td>1.32</td><td>0.128</td><td>0.301</td><td>1.000</td><td>291</td><td>tags=41%, list=23%, signal=51%</td></tr><tr><td class='lessen'>290</td><td>DEMAGALHAES_AGING_UP</td><td></td><td>15</td><td>0.39</td><td>1.32</td><td>0.141</td><td>0.304</td><td>1.000</td><td>202</td><td>tags=47%, list=16%, signal=55%</td></tr><tr><td class='lessen'>291</td><td>SCHUHMACHER_MYC_TARGETS_UP</td><td></td><td>17</td><td>0.37</td><td>1.32</td><td>0.153</td><td>0.305</td><td>1.000</td><td>422</td><td>tags=65%, list=33%, signal=96%</td></tr><tr><td class='lessen'>292</td><td>LANDIS_ERBB2_BREAST_TUMORS_324_UP</td><td></td><td>31</td><td>0.31</td><td>1.32</td><td>0.140</td><td>0.305</td><td>1.000</td><td>333</td><td>tags=42%, list=26%, signal=55%</td></tr><tr><td class='lessen'>293</td><td>MORI_LARGE_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>24</td><td>0.34</td><td>1.32</td><td>0.144</td><td>0.304</td><td>1.000</td><td>140</td><td>tags=29%, list=11%, signal=32%</td></tr><tr><td class='lessen'>294</td><td>WHITFIELD_CELL_CYCLE_G2_M</td><td></td><td>20</td><td>0.36</td><td>1.31</td><td>0.151</td><td>0.314</td><td>1.000</td><td>240</td><td>tags=40%, list=19%, signal=49%</td></tr><tr><td class='lessen'>295</td><td>CAFFAREL_RESPONSE_TO_THC_24HR_5_DN</td><td></td><td>15</td><td>0.39</td><td>1.31</td><td>0.178</td><td>0.313</td><td>1.000</td><td>451</td><td>tags=60%, list=35%, signal=92%</td></tr><tr><td class='lessen'>296</td><td>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP</td><td></td><td>17</td><td>0.37</td><td>1.31</td><td>0.157</td><td>0.316</td><td>1.000</td><td>465</td><td>tags=65%, list=37%, signal=101%</td></tr><tr><td class='lessen'>297</td><td>LIU_PROSTATE_CANCER_DN</td><td></td><td>42</td><td>0.28</td><td>1.30</td><td>0.119</td><td>0.320</td><td>1.000</td><td>190</td><td>tags=24%, list=15%, signal=27%</td></tr><tr><td class='lessen'>298</td><td>VANOEVELEN_MYOGENESIS_SIN3A_TARGETS</td><td></td><td>18</td><td>0.37</td><td>1.29</td><td>0.185</td><td>0.339</td><td>1.000</td><td>321</td><td>tags=39%, list=25%, signal=51%</td></tr><tr><td class='lessen'>299</td><td>CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP</td><td></td><td>18</td><td>0.36</td><td>1.29</td><td>0.160</td><td>0.341</td><td>1.000</td><td>98</td><td>tags=22%, list=8%, signal=24%</td></tr><tr><td class='lessen'>300</td><td>KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3</td><td></td><td>131</td><td>0.22</td><td>1.29</td><td>0.084</td><td>0.342</td><td>1.000</td><td>243</td><td>tags=24%, list=19%, signal=27%</td></tr><tr><td class='lessen'>301</td><td>HELLER_SILENCED_BY_METHYLATION_UP</td><td></td><td>27</td><td>0.32</td><td>1.28</td><td>0.166</td><td>0.345</td><td>1.000</td><td>44</td><td>tags=15%, list=3%, signal=15%</td></tr><tr><td class='lessen'>302</td><td>LOPEZ_MBD_TARGETS</td><td></td><td>170</td><td>0.21</td><td>1.28</td><td>0.070</td><td>0.350</td><td>1.000</td><td>293</td><td>tags=31%, list=23%, signal=34%</td></tr><tr><td class='lessen'>303</td><td>BURTON_ADIPOGENESIS_2</td><td></td><td>17</td><td>0.37</td><td>1.28</td><td>0.167</td><td>0.354</td><td>1.000</td><td>467</td><td>tags=71%, list=37%, signal=110%</td></tr><tr><td class='lessen'>304</td><td>SMID_BREAST_CANCER_BASAL_UP</td><td></td><td>69</td><td>0.25</td><td>1.28</td><td>0.143</td><td>0.354</td><td>1.000</td><td>328</td><td>tags=38%, list=26%, signal=48%</td></tr><tr><td class='lessen'>305</td><td>BROWN_MYELOID_CELL_DEVELOPMENT_UP</td><td></td><td>37</td><td>0.29</td><td>1.27</td><td>0.180</td><td>0.361</td><td>1.000</td><td>202</td><td>tags=32%, list=16%, signal=37%</td></tr><tr><td class='lessen'>306</td><td>KAYO_AGING_MUSCLE_DN</td><td></td><td>27</td><td>0.31</td><td>1.27</td><td>0.179</td><td>0.366</td><td>1.000</td><td>159</td><td>tags=26%, list=13%, signal=29%</td></tr><tr><td class='lessen'>307</td><td>REACTOME_TP53_REGULATES_METABOLIC_GENES</td><td></td><td>17</td><td>0.36</td><td>1.27</td><td>0.159</td><td>0.366</td><td>1.000</td><td>405</td><td>tags=65%, list=32%, signal=94%</td></tr><tr><td class='lessen'>308</td><td>HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP</td><td></td><td>18</td><td>0.36</td><td>1.27</td><td>0.204</td><td>0.366</td><td>1.000</td><td>292</td><td>tags=50%, list=23%, signal=64%</td></tr><tr><td class='lessen'>309</td><td>REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1</td><td></td><td>25</td><td>0.32</td><td>1.27</td><td>0.184</td><td>0.366</td><td>1.000</td><td>670</td><td>tags=84%, list=53%, signal=174%</td></tr><tr><td class='lessen'>310</td><td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP</td><td></td><td>31</td><td>0.30</td><td>1.26</td><td>0.157</td><td>0.366</td><td>1.000</td><td>350</td><td>tags=42%, list=28%, signal=56%</td></tr><tr><td class='lessen'>311</td><td>AMUNDSON_RESPONSE_TO_ARSENITE</td><td></td><td>19</td><td>0.35</td><td>1.26</td><td>0.191</td><td>0.367</td><td>1.000</td><td>152</td><td>tags=32%, list=12%, signal=35%</td></tr><tr><td class='lessen'>312</td><td>KEGG_FOCAL_ADHESION</td><td></td><td>18</td><td>0.35</td><td>1.25</td><td>0.183</td><td>0.386</td><td>1.000</td><td>237</td><td>tags=39%, list=19%, signal=47%</td></tr><tr><td class='lessen'>313</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S1</td><td></td><td>29</td><td>0.30</td><td>1.25</td><td>0.189</td><td>0.388</td><td>1.000</td><td>312</td><td>tags=41%, list=25%, signal=54%</td></tr><tr><td class='lessen'>314</td><td>ZHU_CMV_24_HR_UP</td><td></td><td>20</td><td>0.33</td><td>1.24</td><td>0.209</td><td>0.400</td><td>1.000</td><td>618</td><td>tags=75%, list=49%, signal=144%</td></tr><tr><td class='lessen'>315</td><td>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN</td><td></td><td>34</td><td>0.29</td><td>1.24</td><td>0.187</td><td>0.403</td><td>1.000</td><td>97</td><td>tags=24%, list=8%, signal=25%</td></tr><tr><td class='lessen'>316</td><td>MARTENS_BOUND_BY_PML_RARA_FUSION</td><td></td><td>47</td><td>0.27</td><td>1.24</td><td>0.151</td><td>0.405</td><td>1.000</td><td>335</td><td>tags=36%, list=26%, signal=47%</td></tr><tr><td class='lessen'>317</td><td>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP</td><td></td><td>22</td><td>0.32</td><td>1.24</td><td>0.198</td><td>0.405</td><td>1.000</td><td>453</td><td>tags=64%, list=36%, signal=97%</td></tr><tr><td class='lessen'>318</td><td>LIU_NASOPHARYNGEAL_CARCINOMA</td><td></td><td>16</td><td>0.36</td><td>1.24</td><td>0.200</td><td>0.405</td><td>1.000</td><td>130</td><td>tags=31%, list=10%, signal=34%</td></tr><tr><td class='lessen'>319</td><td>PASINI_SUZ12_TARGETS_DN</td><td></td><td>68</td><td>0.24</td><td>1.23</td><td>0.169</td><td>0.407</td><td>1.000</td><td>265</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>320</td><td>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN</td><td></td><td>20</td><td>0.33</td><td>1.23</td><td>0.189</td><td>0.406</td><td>1.000</td><td>392</td><td>tags=60%, list=31%, signal=85%</td></tr><tr><td class='lessen'>321</td><td>BRUINS_UVC_RESPONSE_EARLY_LATE</td><td></td><td>24</td><td>0.31</td><td>1.23</td><td>0.188</td><td>0.407</td><td>1.000</td><td>218</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>322</td><td>REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_</td><td></td><td>19</td><td>0.34</td><td>1.23</td><td>0.218</td><td>0.406</td><td>1.000</td><td>689</td><td>tags=89%, list=54%, signal=192%</td></tr><tr><td class='lessen'>323</td><td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN</td><td></td><td>20</td><td>0.33</td><td>1.23</td><td>0.208</td><td>0.408</td><td>1.000</td><td>585</td><td>tags=80%, list=46%, signal=146%</td></tr><tr><td class='lessen'>324</td><td>BENPORATH_ES_1</td><td></td><td>44</td><td>0.27</td><td>1.23</td><td>0.166</td><td>0.409</td><td>1.000</td><td>173</td><td>tags=25%, list=14%, signal=28%</td></tr><tr><td class='lessen'>325</td><td>REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION</td><td></td><td>18</td><td>0.35</td><td>1.23</td><td>0.212</td><td>0.408</td><td>1.000</td><td>313</td><td>tags=50%, list=25%, signal=65%</td></tr><tr><td class='lessen'>326</td><td>REACTOME_SUMOYLATION</td><td></td><td>19</td><td>0.34</td><td>1.23</td><td>0.213</td><td>0.408</td><td>1.000</td><td>709</td><td>tags=89%, list=56%, signal=199%</td></tr><tr><td class='lessen'>327</td><td>REACTOME_RHO_GTPASE_EFFECTORS</td><td></td><td>38</td><td>0.28</td><td>1.23</td><td>0.189</td><td>0.409</td><td>1.000</td><td>502</td><td>tags=58%, list=39%, signal=93%</td></tr><tr><td class='lessen'>328</td><td>WP_SPINAL_CORD_INJURY</td><td></td><td>17</td><td>0.35</td><td>1.23</td><td>0.235</td><td>0.408</td><td>1.000</td><td>237</td><td>tags=41%, list=19%, signal=50%</td></tr><tr><td class='lessen'>329</td><td>KIM_WT1_TARGETS_8HR_UP</td><td></td><td>23</td><td>0.32</td><td>1.23</td><td>0.241</td><td>0.410</td><td>1.000</td><td>315</td><td>tags=48%, list=25%, signal=62%</td></tr><tr><td class='lessen'>330</td><td>WP_RETINOBLASTOMA_GENE_IN_CANCER</td><td></td><td>17</td><td>0.35</td><td>1.22</td><td>0.231</td><td>0.410</td><td>1.000</td><td>258</td><td>tags=35%, list=20%, signal=44%</td></tr><tr><td class='lessen'>331</td><td>YAGI_AML_SURVIVAL</td><td></td><td>17</td><td>0.34</td><td>1.22</td><td>0.236</td><td>0.409</td><td>1.000</td><td>345</td><td>tags=47%, list=27%, signal=64%</td></tr><tr><td class='lessen'>332</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>120</td><td>0.22</td><td>1.22</td><td>0.134</td><td>0.410</td><td>1.000</td><td>235</td><td>tags=27%, list=18%, signal=30%</td></tr><tr><td class='lessen'>333</td><td>REACTOME_CELL_CYCLE_CHECKPOINTS</td><td></td><td>35</td><td>0.28</td><td>1.22</td><td>0.196</td><td>0.409</td><td>1.000</td><td>684</td><td>tags=83%, list=54%, signal=174%</td></tr><tr><td class='lessen'>334</td><td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN</td><td></td><td>29</td><td>0.30</td><td>1.22</td><td>0.193</td><td>0.413</td><td>1.000</td><td>264</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>335</td><td>BLALOCK_ALZHEIMERS_DISEASE_DN</td><td></td><td>160</td><td>0.21</td><td>1.22</td><td>0.109</td><td>0.420</td><td>1.000</td><td>250</td><td>tags=26%, list=20%, signal=28%</td></tr><tr><td class='lessen'>336</td><td>WP_FOCAL_ADHESION</td><td></td><td>20</td><td>0.33</td><td>1.21</td><td>0.225</td><td>0.426</td><td>1.000</td><td>562</td><td>tags=75%, list=44%, signal=132%</td></tr><tr><td class='lessen'>337</td><td>SENESE_HDAC1_AND_HDAC2_TARGETS_UP</td><td></td><td>21</td><td>0.31</td><td>1.21</td><td>0.205</td><td>0.430</td><td>1.000</td><td>394</td><td>tags=52%, list=31%, signal=75%</td></tr><tr><td class='lessen'>338</td><td>GRUETZMANN_PANCREATIC_CANCER_DN</td><td></td><td>43</td><td>0.26</td><td>1.21</td><td>0.187</td><td>0.429</td><td>1.000</td><td>188</td><td>tags=28%, list=15%, signal=32%</td></tr><tr><td class='lessen'>339</td><td>GRYDER_PAX3FOXO1_TOP_ENHANCERS</td><td></td><td>47</td><td>0.26</td><td>1.20</td><td>0.186</td><td>0.439</td><td>1.000</td><td>444</td><td>tags=51%, list=35%, signal=76%</td></tr><tr><td class='lessen'>340</td><td>REACTOME_SIGNALING_BY_INTERLEUKINS</td><td></td><td>57</td><td>0.25</td><td>1.20</td><td>0.208</td><td>0.440</td><td>1.000</td><td>409</td><td>tags=46%, list=32%, signal=64%</td></tr><tr><td class='lessen'>341</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9</td><td></td><td>22</td><td>0.30</td><td>1.20</td><td>0.227</td><td>0.443</td><td>1.000</td><td>306</td><td>tags=45%, list=24%, signal=59%</td></tr><tr><td class='lessen'>342</td><td>REACTOME_MITOTIC_G2_G2_M_PHASES</td><td></td><td>29</td><td>0.29</td><td>1.20</td><td>0.221</td><td>0.443</td><td>1.000</td><td>397</td><td>tags=45%, list=31%, signal=64%</td></tr><tr><td class='lessen'>343</td><td>JOHNSTONE_PARVB_TARGETS_3_DN</td><td></td><td>102</td><td>0.21</td><td>1.20</td><td>0.158</td><td>0.444</td><td>1.000</td><td>548</td><td>tags=59%, list=43%, signal=95%</td></tr><tr><td class='lessen'>344</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN</td><td></td><td>45</td><td>0.26</td><td>1.19</td><td>0.226</td><td>0.450</td><td>1.000</td><td>338</td><td>tags=44%, list=27%, signal=58%</td></tr><tr><td class='lessen'>345</td><td>BASAKI_YBX1_TARGETS_UP</td><td></td><td>46</td><td>0.25</td><td>1.19</td><td>0.219</td><td>0.453</td><td>1.000</td><td>502</td><td>tags=54%, list=39%, signal=87%</td></tr><tr><td class='lessen'>346</td><td>MILI_PSEUDOPODIA_CHEMOTAXIS_DN</td><td></td><td>66</td><td>0.24</td><td>1.19</td><td>0.191</td><td>0.451</td><td>1.000</td><td>79</td><td>tags=15%, list=6%, signal=15%</td></tr><tr><td class='lessen'>347</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN</td><td></td><td>36</td><td>0.27</td><td>1.19</td><td>0.225</td><td>0.455</td><td>1.000</td><td>649</td><td>tags=78%, list=51%, signal=154%</td></tr><tr><td class='lessen'>348</td><td>CHANDRAN_METASTASIS_UP</td><td></td><td>22</td><td>0.31</td><td>1.18</td><td>0.255</td><td>0.458</td><td>1.000</td><td>458</td><td>tags=55%, list=36%, signal=84%</td></tr><tr><td class='lessen'>349</td><td>REACTOME_PROGRAMMED_CELL_DEATH</td><td></td><td>37</td><td>0.27</td><td>1.18</td><td>0.226</td><td>0.457</td><td>1.000</td><td>397</td><td>tags=43%, list=31%, signal=61%</td></tr><tr><td class='lessen'>350</td><td>MATSUDA_NATURAL_KILLER_DIFFERENTIATION</td><td></td><td>81</td><td>0.23</td><td>1.18</td><td>0.203</td><td>0.457</td><td>1.000</td><td>347</td><td>tags=41%, list=27%, signal=52%</td></tr><tr><td class='lessen'>351</td><td>MANALO_HYPOXIA_DN</td><td></td><td>35</td><td>0.27</td><td>1.18</td><td>0.261</td><td>0.456</td><td>1.000</td><td>682</td><td>tags=83%, list=54%, signal=174%</td></tr><tr><td class='lessen'>352</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS</td><td></td><td>83</td><td>0.22</td><td>1.18</td><td>0.212</td><td>0.456</td><td>1.000</td><td>384</td><td>tags=45%, list=30%, signal=60%</td></tr><tr><td class='lessen'>353</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1</td><td></td><td>39</td><td>0.27</td><td>1.18</td><td>0.235</td><td>0.457</td><td>1.000</td><td>306</td><td>tags=41%, list=24%, signal=52%</td></tr><tr><td class='lessen'>354</td><td>BENPORATH_CYCLING_GENES</td><td></td><td>67</td><td>0.23</td><td>1.18</td><td>0.212</td><td>0.457</td><td>1.000</td><td>518</td><td>tags=60%, list=41%, signal=95%</td></tr><tr><td class='lessen'>355</td><td>PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP</td><td></td><td>18</td><td>0.33</td><td>1.18</td><td>0.255</td><td>0.456</td><td>1.000</td><td>151</td><td>tags=28%, list=12%, signal=31%</td></tr><tr><td class='lessen'>356</td><td>REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE</td><td></td><td>33</td><td>0.28</td><td>1.18</td><td>0.255</td><td>0.456</td><td>1.000</td><td>684</td><td>tags=79%, list=54%, signal=166%</td></tr><tr><td class='lessen'>357</td><td>JOHNSTONE_PARVB_TARGETS_2_UP</td><td></td><td>30</td><td>0.29</td><td>1.18</td><td>0.248</td><td>0.458</td><td>1.000</td><td>134</td><td>tags=23%, list=11%, signal=25%</td></tr><tr><td class='lessen'>358</td><td>NABA_MATRISOME</td><td></td><td>49</td><td>0.25</td><td>1.17</td><td>0.233</td><td>0.466</td><td>1.000</td><td>245</td><td>tags=31%, list=19%, signal=36%</td></tr><tr><td class='lessen'>359</td><td>KEGG_CELL_CYCLE</td><td></td><td>15</td><td>0.35</td><td>1.17</td><td>0.267</td><td>0.476</td><td>1.000</td><td>370</td><td>tags=53%, list=29%, signal=74%</td></tr><tr><td class='lessen'>360</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10</td><td></td><td>21</td><td>0.31</td><td>1.17</td><td>0.265</td><td>0.480</td><td>1.000</td><td>497</td><td>tags=67%, list=39%, signal=108%</td></tr><tr><td class='lessen'>361</td><td>MUNSHI_MULTIPLE_MYELOMA_UP</td><td></td><td>18</td><td>0.33</td><td>1.17</td><td>0.277</td><td>0.479</td><td>1.000</td><td>227</td><td>tags=39%, list=18%, signal=47%</td></tr><tr><td class='lessen'>362</td><td>FUJII_YBX1_TARGETS_DN</td><td></td><td>23</td><td>0.31</td><td>1.16</td><td>0.261</td><td>0.478</td><td>1.000</td><td>699</td><td>tags=91%, list=55%, signal=199%</td></tr><tr><td class='lessen'>363</td><td>REACTOME_PROTEIN_FOLDING</td><td></td><td>15</td><td>0.34</td><td>1.16</td><td>0.291</td><td>0.477</td><td>1.000</td><td>554</td><td>tags=73%, list=44%, signal=128%</td></tr><tr><td class='lessen'>364</td><td>ZHU_CMV_ALL_UP</td><td></td><td>22</td><td>0.30</td><td>1.16</td><td>0.263</td><td>0.480</td><td>1.000</td><td>622</td><td>tags=73%, list=49%, signal=140%</td></tr><tr><td class='lessen'>365</td><td>MEBARKI_HCC_PROGENITOR_FZD8CRD_UP</td><td></td><td>37</td><td>0.26</td><td>1.16</td><td>0.261</td><td>0.480</td><td>1.000</td><td>685</td><td>tags=81%, list=54%, signal=171%</td></tr><tr><td class='lessen'>366</td><td>WP_CELL_CYCLE</td><td></td><td>15</td><td>0.35</td><td>1.16</td><td>0.284</td><td>0.484</td><td>1.000</td><td>370</td><td>tags=53%, list=29%, signal=74%</td></tr><tr><td class='lessen'>367</td><td>REACTOME_RHO_GTPASES_ACTIVATE_FORMINS</td><td></td><td>15</td><td>0.34</td><td>1.16</td><td>0.280</td><td>0.486</td><td>1.000</td><td>843</td><td>tags=100%, list=66%, signal=293%</td></tr><tr><td class='lessen'>368</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN</td><td></td><td>37</td><td>0.25</td><td>1.16</td><td>0.256</td><td>0.486</td><td>1.000</td><td>339</td><td>tags=41%, list=27%, signal=54%</td></tr><tr><td class='lessen'>369</td><td>TAKAO_RESPONSE_TO_UVB_RADIATION_DN</td><td></td><td>22</td><td>0.31</td><td>1.16</td><td>0.291</td><td>0.485</td><td>1.000</td><td>346</td><td>tags=45%, list=27%, signal=61%</td></tr><tr><td class='lessen'>370</td><td>KEGG_TIGHT_JUNCTION</td><td></td><td>18</td><td>0.32</td><td>1.15</td><td>0.280</td><td>0.486</td><td>1.000</td><td>203</td><td>tags=33%, list=16%, signal=39%</td></tr><tr><td class='lessen'>371</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS</td><td></td><td>19</td><td>0.32</td><td>1.15</td><td>0.280</td><td>0.485</td><td>1.000</td><td>561</td><td>tags=74%, list=44%, signal=130%</td></tr><tr><td class='lessen'>372</td><td>MORI_PRE_BI_LYMPHOCYTE_UP</td><td></td><td>17</td><td>0.33</td><td>1.15</td><td>0.300</td><td>0.485</td><td>1.000</td><td>368</td><td>tags=59%, list=29%, signal=82%</td></tr><tr><td class='lessen'>373</td><td>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP</td><td></td><td>73</td><td>0.22</td><td>1.15</td><td>0.239</td><td>0.488</td><td>1.000</td><td>281</td><td>tags=33%, list=22%, signal=40%</td></tr><tr><td class='lessen'>374</td><td>LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER</td><td></td><td>25</td><td>0.30</td><td>1.15</td><td>0.272</td><td>0.490</td><td>1.000</td><td>236</td><td>tags=28%, list=19%, signal=34%</td></tr><tr><td class='lessen'>375</td><td>WEST_ADRENOCORTICAL_TUMOR_UP</td><td></td><td>45</td><td>0.25</td><td>1.15</td><td>0.280</td><td>0.493</td><td>1.000</td><td>435</td><td>tags=47%, list=34%, signal=68%</td></tr><tr><td class='lessen'>376</td><td>THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN</td><td></td><td>27</td><td>0.28</td><td>1.14</td><td>0.306</td><td>0.509</td><td>1.000</td><td>579</td><td>tags=70%, list=46%, signal=127%</td></tr><tr><td class='lessen'>377</td><td>MORI_IMMATURE_B_LYMPHOCYTE_DN</td><td></td><td>21</td><td>0.30</td><td>1.14</td><td>0.290</td><td>0.510</td><td>1.000</td><td>457</td><td>tags=62%, list=36%, signal=95%</td></tr><tr><td class='lessen'>378</td><td>SCHLOSSER_SERUM_RESPONSE_DN</td><td></td><td>101</td><td>0.20</td><td>1.14</td><td>0.227</td><td>0.513</td><td>1.000</td><td>201</td><td>tags=22%, list=16%, signal=24%</td></tr><tr><td class='lessen'>379</td><td>MILI_PSEUDOPODIA_HAPTOTAXIS_DN</td><td></td><td>78</td><td>0.22</td><td>1.13</td><td>0.260</td><td>0.513</td><td>1.000</td><td>79</td><td>tags=13%, list=6%, signal=13%</td></tr><tr><td class='lessen'>380</td><td>NABA_MATRISOME_ASSOCIATED</td><td></td><td>43</td><td>0.25</td><td>1.13</td><td>0.305</td><td>0.512</td><td>1.000</td><td>202</td><td>tags=28%, list=16%, signal=32%</td></tr><tr><td class='lessen'>381</td><td>REACTOME_G2_M_CHECKPOINTS</td><td></td><td>23</td><td>0.29</td><td>1.13</td><td>0.317</td><td>0.523</td><td>1.000</td><td>670</td><td>tags=83%, list=53%, signal=172%</td></tr><tr><td class='lessen'>382</td><td>MEBARKI_HCC_PROGENITOR_WNT_UP</td><td></td><td>15</td><td>0.33</td><td>1.12</td><td>0.325</td><td>0.541</td><td>1.000</td><td>267</td><td>tags=40%, list=21%, signal=50%</td></tr><tr><td class='lessen'>383</td><td>LI_INDUCED_T_TO_NATURAL_KILLER_UP</td><td></td><td>51</td><td>0.23</td><td>1.12</td><td>0.322</td><td>0.542</td><td>1.000</td><td>194</td><td>tags=24%, list=15%, signal=27%</td></tr><tr><td class='lessen'>384</td><td>KOYAMA_SEMA3B_TARGETS_UP</td><td></td><td>21</td><td>0.29</td><td>1.10</td><td>0.333</td><td>0.577</td><td>1.000</td><td>267</td><td>tags=38%, list=21%, signal=47%</td></tr><tr><td class='lessen'>385</td><td>GAL_LEUKEMIC_STEM_CELL_DN</td><td></td><td>22</td><td>0.29</td><td>1.10</td><td>0.356</td><td>0.580</td><td>1.000</td><td>190</td><td>tags=27%, list=15%, signal=32%</td></tr><tr><td class='lessen'>386</td><td>ENK_UV_RESPONSE_KERATINOCYTE_DN</td><td></td><td>71</td><td>0.21</td><td>1.09</td><td>0.309</td><td>0.591</td><td>1.000</td><td>617</td><td>tags=65%, list=49%, signal=119%</td></tr><tr><td class='lessen'>387</td><td>TOOKER_GEMCITABINE_RESISTANCE_UP</td><td></td><td>16</td><td>0.32</td><td>1.09</td><td>0.332</td><td>0.590</td><td>1.000</td><td>324</td><td>tags=44%, list=25%, signal=58%</td></tr><tr><td class='lessen'>388</td><td>KEGG_OXIDATIVE_PHOSPHORYLATION</td><td></td><td>19</td><td>0.30</td><td>1.09</td><td>0.353</td><td>0.600</td><td>1.000</td><td>689</td><td>tags=89%, list=54%, signal=192%</td></tr><tr><td class='lessen'>389</td><td>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN</td><td></td><td>15</td><td>0.32</td><td>1.08</td><td>0.365</td><td>0.606</td><td>1.000</td><td>66</td><td>tags=20%, list=5%, signal=21%</td></tr><tr><td class='lessen'>390</td><td>DELYS_THYROID_CANCER_UP</td><td></td><td>65</td><td>0.21</td><td>1.08</td><td>0.356</td><td>0.614</td><td>1.000</td><td>257</td><td>tags=26%, list=20%, signal=31%</td></tr><tr><td class='lessen'>391</td><td>ALCALA_APOPTOSIS</td><td></td><td>15</td><td>0.32</td><td>1.08</td><td>0.366</td><td>0.613</td><td>1.000</td><td>164</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>392</td><td>PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN</td><td></td><td>18</td><td>0.31</td><td>1.08</td><td>0.358</td><td>0.612</td><td>1.000</td><td>390</td><td>tags=56%, list=31%, signal=79%</td></tr><tr><td class='lessen'>393</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_1_DN</td><td></td><td>47</td><td>0.23</td><td>1.08</td><td>0.368</td><td>0.611</td><td>1.000</td><td>258</td><td>tags=30%, list=20%, signal=36%</td></tr><tr><td class='lessen'>394</td><td>REACTOME_ESR_MEDIATED_SIGNALING</td><td></td><td>27</td><td>0.26</td><td>1.08</td><td>0.366</td><td>0.610</td><td>1.000</td><td>313</td><td>tags=41%, list=25%, signal=53%</td></tr><tr><td class='lessen'>395</td><td>REACTOME_SIGNALING_BY_RHO_GTPASES</td><td></td><td>41</td><td>0.24</td><td>1.07</td><td>0.372</td><td>0.615</td><td>1.000</td><td>502</td><td>tags=54%, list=39%, signal=86%</td></tr><tr><td class='lessen'>396</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP</td><td></td><td>17</td><td>0.30</td><td>1.07</td><td>0.397</td><td>0.623</td><td>1.000</td><td>165</td><td>tags=29%, list=13%, signal=33%</td></tr><tr><td class='lessen'>397</td><td>AFFAR_YY1_TARGETS_DN</td><td></td><td>33</td><td>0.25</td><td>1.07</td><td>0.365</td><td>0.623</td><td>1.000</td><td>108</td><td>tags=18%, list=8%, signal=19%</td></tr><tr><td class='lessen'>398</td><td>GROSS_HYPOXIA_VIA_ELK3_UP</td><td></td><td>48</td><td>0.23</td><td>1.07</td><td>0.360</td><td>0.623</td><td>1.000</td><td>464</td><td>tags=54%, list=37%, signal=82%</td></tr><tr><td class='lessen'>399</td><td>CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN</td><td></td><td>32</td><td>0.25</td><td>1.07</td><td>0.358</td><td>0.624</td><td>1.000</td><td>236</td><td>tags=31%, list=19%, signal=37%</td></tr><tr><td class='lessen'>400</td><td>HUPER_BREAST_BASAL_VS_LUMINAL_DN</td><td></td><td>17</td><td>0.31</td><td>1.07</td><td>0.384</td><td>0.623</td><td>1.000</td><td>212</td><td>tags=41%, list=17%, signal=49%</td></tr><tr><td class='lessen'>401</td><td>JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP</td><td></td><td>35</td><td>0.24</td><td>1.06</td><td>0.371</td><td>0.631</td><td>1.000</td><td>318</td><td>tags=37%, list=25%, signal=48%</td></tr><tr><td class='lessen'>402</td><td>REACTOME_CELL_JUNCTION_ORGANIZATION</td><td></td><td>15</td><td>0.31</td><td>1.05</td><td>0.403</td><td>0.664</td><td>1.000</td><td>233</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>403</td><td>NABA_ECM_AFFILIATED</td><td></td><td>17</td><td>0.30</td><td>1.05</td><td>0.400</td><td>0.665</td><td>1.000</td><td>202</td><td>tags=35%, list=16%, signal=41%</td></tr><tr><td class='lessen'>404</td><td>GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB</td><td></td><td>20</td><td>0.29</td><td>1.05</td><td>0.411</td><td>0.663</td><td>1.000</td><td>409</td><td>tags=50%, list=32%, signal=73%</td></tr><tr><td class='lessen'>405</td><td>REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT</td><td></td><td>27</td><td>0.26</td><td>1.05</td><td>0.400</td><td>0.664</td><td>1.000</td><td>684</td><td>tags=78%, list=54%, signal=165%</td></tr><tr><td class='lessen'>406</td><td>HOLLMANN_APOPTOSIS_VIA_CD40_UP</td><td></td><td>26</td><td>0.26</td><td>1.04</td><td>0.428</td><td>0.667</td><td>1.000</td><td>298</td><td>tags=38%, list=23%, signal=49%</td></tr><tr><td class='lessen'>407</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_2</td><td></td><td>24</td><td>0.27</td><td>1.04</td><td>0.419</td><td>0.666</td><td>1.000</td><td>261</td><td>tags=38%, list=21%, signal=46%</td></tr><tr><td class='lessen'>408</td><td>GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN</td><td></td><td>43</td><td>0.23</td><td>1.04</td><td>0.371</td><td>0.671</td><td>1.000</td><td>408</td><td>tags=42%, list=32%, signal=60%</td></tr><tr><td class='lessen'>409</td><td>WEST_ADRENOCORTICAL_TUMOR_DN</td><td></td><td>60</td><td>0.21</td><td>1.04</td><td>0.413</td><td>0.679</td><td>1.000</td><td>152</td><td>tags=20%, list=12%, signal=22%</td></tr><tr><td class='lessen'>410</td><td>BLALOCK_ALZHEIMERS_DISEASE_UP</td><td></td><td>171</td><td>0.17</td><td>1.04</td><td>0.375</td><td>0.678</td><td>1.000</td><td>229</td><td>tags=22%, list=18%, signal=23%</td></tr><tr><td class='lessen'>411</td><td>BORLAK_LIVER_CANCER_EGF_UP</td><td></td><td>21</td><td>0.28</td><td>1.03</td><td>0.398</td><td>0.679</td><td>1.000</td><td>154</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>412</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP</td><td></td><td>77</td><td>0.20</td><td>1.03</td><td>0.421</td><td>0.682</td><td>1.000</td><td>257</td><td>tags=27%, list=20%, signal=32%</td></tr><tr><td class='lessen'>413</td><td>REACTOME_CELL_CELL_COMMUNICATION</td><td></td><td>16</td><td>0.30</td><td>1.03</td><td>0.434</td><td>0.681</td><td>1.000</td><td>409</td><td>tags=50%, list=32%, signal=73%</td></tr><tr><td class='lessen'>414</td><td>REACTOME_INTERLEUKIN_1_SIGNALING</td><td></td><td>20</td><td>0.28</td><td>1.03</td><td>0.433</td><td>0.681</td><td>1.000</td><td>97</td><td>tags=15%, list=8%, signal=16%</td></tr><tr><td class='lessen'>415</td><td>RAMALHO_STEMNESS_UP</td><td></td><td>27</td><td>0.26</td><td>1.03</td><td>0.414</td><td>0.681</td><td>1.000</td><td>438</td><td>tags=52%, list=34%, signal=77%</td></tr><tr><td class='lessen'>416</td><td>BAE_BRCA1_TARGETS_UP</td><td></td><td>25</td><td>0.26</td><td>1.02</td><td>0.443</td><td>0.712</td><td>1.000</td><td>433</td><td>tags=52%, list=34%, signal=77%</td></tr><tr><td class='lessen'>417</td><td>BRUNO_HEMATOPOIESIS</td><td></td><td>15</td><td>0.30</td><td>1.01</td><td>0.444</td><td>0.713</td><td>1.000</td><td>75</td><td>tags=13%, list=6%, signal=14%</td></tr><tr><td class='lessen'>418</td><td>REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION</td><td></td><td>17</td><td>0.29</td><td>1.01</td><td>0.466</td><td>0.729</td><td>1.000</td><td>592</td><td>tags=76%, list=47%, signal=141%</td></tr><tr><td class='lessen'>419</td><td>RIGGI_EWING_SARCOMA_PROGENITOR_DN</td><td></td><td>15</td><td>0.29</td><td>1.01</td><td>0.464</td><td>0.729</td><td>1.000</td><td>286</td><td>tags=40%, list=23%, signal=51%</td></tr><tr><td class='lessen'>420</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4</td><td></td><td>16</td><td>0.29</td><td>1.01</td><td>0.452</td><td>0.727</td><td>1.000</td><td>58</td><td>tags=13%, list=5%, signal=13%</td></tr><tr><td class='lessen'>421</td><td>LEE_NEURAL_CREST_STEM_CELL_UP</td><td></td><td>15</td><td>0.29</td><td>1.00</td><td>0.462</td><td>0.737</td><td>1.000</td><td>209</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>422</td><td>KEGG_REGULATION_OF_ACTIN_CYTOSKELETON</td><td></td><td>16</td><td>0.29</td><td>1.00</td><td>0.464</td><td>0.740</td><td>1.000</td><td>134</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>423</td><td>KOYAMA_SEMA3B_TARGETS_DN</td><td></td><td>30</td><td>0.24</td><td>1.00</td><td>0.447</td><td>0.739</td><td>1.000</td><td>138</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>424</td><td>SMID_BREAST_CANCER_LUMINAL_B_DN</td><td></td><td>50</td><td>0.21</td><td>1.00</td><td>0.471</td><td>0.738</td><td>1.000</td><td>328</td><td>tags=36%, list=26%, signal=47%</td></tr><tr><td class='lessen'>425</td><td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN</td><td></td><td>37</td><td>0.23</td><td>1.00</td><td>0.473</td><td>0.739</td><td>1.000</td><td>237</td><td>tags=27%, list=19%, signal=32%</td></tr><tr><td class='lessen'>426</td><td>REACTOME_SEPARATION_OF_SISTER_CHROMATIDS</td><td></td><td>27</td><td>0.25</td><td>1.00</td><td>0.484</td><td>0.739</td><td>1.000</td><td>684</td><td>tags=78%, list=54%, signal=165%</td></tr><tr><td class='lessen'>427</td><td>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP</td><td></td><td>18</td><td>0.28</td><td>0.99</td><td>0.467</td><td>0.743</td><td>1.000</td><td>193</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>428</td><td>BILD_MYC_ONCOGENIC_SIGNATURE</td><td></td><td>17</td><td>0.28</td><td>0.99</td><td>0.487</td><td>0.742</td><td>1.000</td><td>92</td><td>tags=18%, list=7%, signal=19%</td></tr><tr><td class='lessen'>429</td><td>SESTO_RESPONSE_TO_UV_C1</td><td></td><td>16</td><td>0.28</td><td>0.99</td><td>0.456</td><td>0.744</td><td>1.000</td><td>14</td><td>tags=13%, list=1%, signal=12%</td></tr><tr><td class='lessen'>430</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_3_UP</td><td></td><td>40</td><td>0.21</td><td>0.99</td><td>0.498</td><td>0.749</td><td>1.000</td><td>406</td><td>tags=45%, list=32%, signal=64%</td></tr><tr><td class='lessen'>431</td><td>ZHU_CMV_ALL_DN</td><td></td><td>18</td><td>0.28</td><td>0.98</td><td>0.508</td><td>0.758</td><td>1.000</td><td>237</td><td>tags=39%, list=19%, signal=47%</td></tr><tr><td class='lessen'>432</td><td>CHYLA_CBFA2T3_TARGETS_UP</td><td></td><td>36</td><td>0.23</td><td>0.98</td><td>0.482</td><td>0.757</td><td>1.000</td><td>212</td><td>tags=25%, list=17%, signal=29%</td></tr><tr><td class='lessen'>433</td><td>LEE_LIVER_CANCER_E2F1_UP</td><td></td><td>19</td><td>0.27</td><td>0.98</td><td>0.464</td><td>0.758</td><td>1.000</td><td>134</td><td>tags=26%, list=11%, signal=29%</td></tr><tr><td class='lessen'>434</td><td>GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN</td><td></td><td>25</td><td>0.24</td><td>0.98</td><td>0.496</td><td>0.760</td><td>1.000</td><td>292</td><td>tags=36%, list=23%, signal=46%</td></tr><tr><td class='lessen'>435</td><td>MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP</td><td></td><td>50</td><td>0.21</td><td>0.98</td><td>0.482</td><td>0.759</td><td>1.000</td><td>336</td><td>tags=42%, list=26%, signal=55%</td></tr><tr><td class='lessen'>436</td><td>SHEN_SMARCA2_TARGETS_UP</td><td></td><td>35</td><td>0.23</td><td>0.98</td><td>0.487</td><td>0.764</td><td>1.000</td><td>741</td><td>tags=83%, list=58%, signal=193%</td></tr><tr><td class='lessen'>437</td><td>REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM</td><td></td><td>95</td><td>0.18</td><td>0.97</td><td>0.488</td><td>0.777</td><td>1.000</td><td>409</td><td>tags=41%, list=32%, signal=56%</td></tr><tr><td class='lessen'>438</td><td>GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS</td><td></td><td>111</td><td>0.17</td><td>0.96</td><td>0.547</td><td>0.791</td><td>1.000</td><td>622</td><td>tags=63%, list=49%, signal=113%</td></tr><tr><td class='lessen'>439</td><td>REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS</td><td></td><td>18</td><td>0.27</td><td>0.96</td><td>0.523</td><td>0.794</td><td>1.000</td><td>45</td><td>tags=11%, list=4%, signal=11%</td></tr><tr><td class='lessen'>440</td><td>REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA</td><td></td><td>19</td><td>0.26</td><td>0.96</td><td>0.528</td><td>0.793</td><td>1.000</td><td>670</td><td>tags=79%, list=53%, signal=164%</td></tr><tr><td class='lessen'>441</td><td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP</td><td></td><td>21</td><td>0.26</td><td>0.96</td><td>0.502</td><td>0.791</td><td>1.000</td><td>140</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>442</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B</td><td></td><td>58</td><td>0.19</td><td>0.96</td><td>0.553</td><td>0.793</td><td>1.000</td><td>219</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>443</td><td>PUJANA_BREAST_CANCER_LIT_INT_NETWORK</td><td></td><td>15</td><td>0.29</td><td>0.96</td><td>0.500</td><td>0.796</td><td>1.000</td><td>649</td><td>tags=80%, list=51%, signal=162%</td></tr><tr><td class='lessen'>444</td><td>REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT</td><td></td><td>20</td><td>0.26</td><td>0.96</td><td>0.525</td><td>0.795</td><td>1.000</td><td>24</td><td>tags=10%, list=2%, signal=10%</td></tr><tr><td class='lessen'>445</td><td>WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER</td><td></td><td>15</td><td>0.28</td><td>0.96</td><td>0.492</td><td>0.795</td><td>1.000</td><td>238</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>446</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR</td><td></td><td>41</td><td>0.21</td><td>0.96</td><td>0.498</td><td>0.794</td><td>1.000</td><td>294</td><td>tags=37%, list=23%, signal=46%</td></tr><tr><td class='lessen'>447</td><td>DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP</td><td></td><td>30</td><td>0.22</td><td>0.95</td><td>0.546</td><td>0.801</td><td>1.000</td><td>284</td><td>tags=33%, list=22%, signal=42%</td></tr><tr><td class='lessen'>448</td><td>REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING</td><td></td><td>22</td><td>0.25</td><td>0.95</td><td>0.519</td><td>0.800</td><td>1.000</td><td>97</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>449</td><td>CAIRO_HEPATOBLASTOMA_UP</td><td></td><td>32</td><td>0.22</td><td>0.95</td><td>0.513</td><td>0.799</td><td>1.000</td><td>336</td><td>tags=34%, list=26%, signal=46%</td></tr><tr><td class='lessen'>450</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11</td><td></td><td>18</td><td>0.27</td><td>0.95</td><td>0.553</td><td>0.807</td><td>1.000</td><td>472</td><td>tags=56%, list=37%, signal=87%</td></tr><tr><td class='lessen'>451</td><td>ALONSO_METASTASIS_UP</td><td></td><td>35</td><td>0.22</td><td>0.95</td><td>0.532</td><td>0.807</td><td>1.000</td><td>293</td><td>tags=37%, list=23%, signal=47%</td></tr><tr><td class='lessen'>452</td><td>REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS</td><td></td><td>19</td><td>0.26</td><td>0.95</td><td>0.527</td><td>0.805</td><td>1.000</td><td>268</td><td>tags=37%, list=21%, signal=46%</td></tr><tr><td class='lessen'>453</td><td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP</td><td></td><td>35</td><td>0.22</td><td>0.95</td><td>0.546</td><td>0.804</td><td>1.000</td><td>206</td><td>tags=26%, list=16%, signal=30%</td></tr><tr><td class='lessen'>454</td><td>MORI_MATURE_B_LYMPHOCYTE_DN</td><td></td><td>17</td><td>0.27</td><td>0.95</td><td>0.526</td><td>0.803</td><td>1.000</td><td>321</td><td>tags=47%, list=25%, signal=62%</td></tr><tr><td class='lessen'>455</td><td>ZHENG_GLIOBLASTOMA_PLASTICITY_UP</td><td></td><td>27</td><td>0.23</td><td>0.95</td><td>0.536</td><td>0.802</td><td>1.000</td><td>538</td><td>tags=63%, list=42%, signal=107%</td></tr><tr><td class='lessen'>456</td><td>WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS</td><td></td><td>22</td><td>0.25</td><td>0.94</td><td>0.537</td><td>0.804</td><td>1.000</td><td>306</td><td>tags=41%, list=24%, signal=53%</td></tr><tr><td class='lessen'>457</td><td>PROVENZANI_METASTASIS_UP</td><td></td><td>35</td><td>0.22</td><td>0.94</td><td>0.541</td><td>0.805</td><td>1.000</td><td>231</td><td>tags=29%, list=18%, signal=34%</td></tr><tr><td class='lessen'>458</td><td>LEE_AGING_CEREBELLUM_UP</td><td></td><td>16</td><td>0.27</td><td>0.94</td><td>0.536</td><td>0.808</td><td>1.000</td><td>193</td><td>tags=31%, list=15%, signal=36%</td></tr><tr><td class='lessen'>459</td><td>LU_AGING_BRAIN_DN</td><td></td><td>22</td><td>0.25</td><td>0.94</td><td>0.553</td><td>0.807</td><td>1.000</td><td>541</td><td>tags=68%, list=43%, signal=117%</td></tr><tr><td class='lessen'>460</td><td>REACTOME_DNA_REPLICATION</td><td></td><td>20</td><td>0.26</td><td>0.93</td><td>0.552</td><td>0.817</td><td>1.000</td><td>670</td><td>tags=80%, list=53%, signal=167%</td></tr><tr><td class='lessen'>461</td><td>REACTOME_METABOLISM_OF_POLYAMINES</td><td></td><td>15</td><td>0.28</td><td>0.93</td><td>0.551</td><td>0.821</td><td>1.000</td><td>711</td><td>tags=87%, list=56%, signal=194%</td></tr><tr><td class='lessen'>462</td><td>PID_MTOR_4PATHWAY</td><td></td><td>16</td><td>0.27</td><td>0.93</td><td>0.535</td><td>0.820</td><td>1.000</td><td>376</td><td>tags=56%, list=30%, signal=79%</td></tr><tr><td class='lessen'>463</td><td>MARSON_BOUND_BY_FOXP3_UNSTIMULATED</td><td></td><td>119</td><td>0.16</td><td>0.93</td><td>0.628</td><td>0.818</td><td>1.000</td><td>290</td><td>tags=27%, list=23%, signal=32%</td></tr><tr><td class='lessen'>464</td><td>ONDER_CDH1_TARGETS_2_DN</td><td></td><td>78</td><td>0.18</td><td>0.93</td><td>0.589</td><td>0.820</td><td>1.000</td><td>238</td><td>tags=26%, list=19%, signal=30%</td></tr><tr><td class='lessen'>465</td><td>REACTOME_SIGNALING_BY_NOTCH4</td><td></td><td>19</td><td>0.26</td><td>0.93</td><td>0.566</td><td>0.821</td><td>1.000</td><td>670</td><td>tags=79%, list=53%, signal=164%</td></tr><tr><td class='lessen'>466</td><td>SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE</td><td></td><td>16</td><td>0.27</td><td>0.93</td><td>0.554</td><td>0.822</td><td>1.000</td><td>117</td><td>tags=19%, list=9%, signal=20%</td></tr><tr><td class='lessen'>467</td><td>REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES</td><td></td><td>26</td><td>0.23</td><td>0.93</td><td>0.566</td><td>0.821</td><td>1.000</td><td>670</td><td>tags=77%, list=53%, signal=159%</td></tr><tr><td class='lessen'>468</td><td>REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS</td><td></td><td>26</td><td>0.23</td><td>0.93</td><td>0.577</td><td>0.824</td><td>1.000</td><td>397</td><td>tags=42%, list=31%, signal=60%</td></tr><tr><td class='lessen'>469</td><td>KIM_ALL_DISORDERS_CALB1_CORR_UP</td><td></td><td>81</td><td>0.18</td><td>0.92</td><td>0.608</td><td>0.827</td><td>1.000</td><td>451</td><td>tags=44%, list=35%, signal=64%</td></tr><tr><td class='lessen'>470</td><td>JOHNSTONE_PARVB_TARGETS_2_DN</td><td></td><td>43</td><td>0.20</td><td>0.92</td><td>0.601</td><td>0.829</td><td>1.000</td><td>475</td><td>tags=58%, list=37%, signal=90%</td></tr><tr><td class='lessen'>471</td><td>REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS</td><td></td><td>27</td><td>0.23</td><td>0.92</td><td>0.579</td><td>0.828</td><td>1.000</td><td>141</td><td>tags=19%, list=11%, signal=20%</td></tr><tr><td class='lessen'>472</td><td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN</td><td></td><td>29</td><td>0.22</td><td>0.92</td><td>0.567</td><td>0.828</td><td>1.000</td><td>686</td><td>tags=79%, list=54%, signal=168%</td></tr><tr><td class='lessen'>473</td><td>YOSHIMURA_MAPK8_TARGETS_DN</td><td></td><td>53</td><td>0.19</td><td>0.92</td><td>0.608</td><td>0.828</td><td>1.000</td><td>253</td><td>tags=25%, list=20%, signal=29%</td></tr><tr><td class='lessen'>474</td><td>FORTSCHEGGER_PHF8_TARGETS_DN</td><td></td><td>81</td><td>0.17</td><td>0.91</td><td>0.625</td><td>0.837</td><td>1.000</td><td>198</td><td>tags=19%, list=16%, signal=21%</td></tr><tr><td class='lessen'>475</td><td>DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP</td><td></td><td>30</td><td>0.22</td><td>0.91</td><td>0.588</td><td>0.835</td><td>1.000</td><td>665</td><td>tags=80%, list=52%, signal=164%</td></tr><tr><td class='lessen'>476</td><td>REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE</td><td></td><td>19</td><td>0.25</td><td>0.91</td><td>0.585</td><td>0.835</td><td>1.000</td><td>670</td><td>tags=79%, list=53%, signal=164%</td></tr><tr><td class='lessen'>477</td><td>CHICAS_RB1_TARGETS_CONFLUENT</td><td></td><td>69</td><td>0.18</td><td>0.91</td><td>0.613</td><td>0.833</td><td>1.000</td><td>147</td><td>tags=14%, list=12%, signal=15%</td></tr><tr><td class='lessen'>478</td><td>WANG_SMARCE1_TARGETS_UP</td><td></td><td>26</td><td>0.23</td><td>0.91</td><td>0.583</td><td>0.833</td><td>1.000</td><td>12</td><td>tags=8%, list=1%, signal=8%</td></tr><tr><td class='lessen'>479</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_DN</td><td></td><td>15</td><td>0.27</td><td>0.91</td><td>0.572</td><td>0.833</td><td>1.000</td><td>100</td><td>tags=20%, list=8%, signal=21%</td></tr><tr><td class='lessen'>480</td><td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP</td><td></td><td>18</td><td>0.26</td><td>0.91</td><td>0.565</td><td>0.834</td><td>1.000</td><td>190</td><td>tags=28%, list=15%, signal=32%</td></tr><tr><td class='lessen'>481</td><td>THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP</td><td></td><td>15</td><td>0.26</td><td>0.91</td><td>0.579</td><td>0.841</td><td>1.000</td><td>210</td><td>tags=33%, list=17%, signal=39%</td></tr><tr><td class='lessen'>482</td><td>ACEVEDO_LIVER_CANCER_UP</td><td></td><td>101</td><td>0.16</td><td>0.90</td><td>0.633</td><td>0.846</td><td>1.000</td><td>122</td><td>tags=13%, list=10%, signal=13%</td></tr><tr><td class='lessen'>483</td><td>LIU_SOX4_TARGETS_DN</td><td></td><td>35</td><td>0.21</td><td>0.90</td><td>0.603</td><td>0.845</td><td>1.000</td><td>180</td><td>tags=17%, list=14%, signal=19%</td></tr><tr><td class='lessen'>484</td><td>REACTOME_MUSCLE_CONTRACTION</td><td></td><td>16</td><td>0.26</td><td>0.90</td><td>0.589</td><td>0.844</td><td>1.000</td><td>364</td><td>tags=50%, list=29%, signal=69%</td></tr><tr><td class='lessen'>485</td><td>REACTOME_DEUBIQUITINATION</td><td></td><td>29</td><td>0.23</td><td>0.90</td><td>0.621</td><td>0.848</td><td>1.000</td><td>670</td><td>tags=76%, list=53%, signal=157%</td></tr><tr><td class='lessen'>486</td><td>MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN</td><td></td><td>52</td><td>0.19</td><td>0.90</td><td>0.635</td><td>0.848</td><td>1.000</td><td>114</td><td>tags=13%, list=9%, signal=14%</td></tr><tr><td class='lessen'>487</td><td>ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN</td><td></td><td>16</td><td>0.26</td><td>0.90</td><td>0.583</td><td>0.848</td><td>1.000</td><td>33</td><td>tags=13%, list=3%, signal=13%</td></tr><tr><td class='lessen'>488</td><td>NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON</td><td></td><td>21</td><td>0.24</td><td>0.90</td><td>0.628</td><td>0.847</td><td>1.000</td><td>285</td><td>tags=38%, list=22%, signal=48%</td></tr><tr><td class='lessen'>489</td><td>WHITFIELD_CELL_CYCLE_G2</td><td></td><td>17</td><td>0.26</td><td>0.89</td><td>0.585</td><td>0.854</td><td>1.000</td><td>253</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>490</td><td>DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN</td><td></td><td>16</td><td>0.26</td><td>0.89</td><td>0.584</td><td>0.858</td><td>1.000</td><td>126</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>491</td><td>GOZGIT_ESR1_TARGETS_DN</td><td></td><td>67</td><td>0.17</td><td>0.89</td><td>0.660</td><td>0.859</td><td>1.000</td><td>167</td><td>tags=18%, list=13%, signal=20%</td></tr><tr><td class='lessen'>492</td><td>XU_GH1_AUTOCRINE_TARGETS_UP</td><td></td><td>23</td><td>0.23</td><td>0.89</td><td>0.587</td><td>0.862</td><td>1.000</td><td>189</td><td>tags=26%, list=15%, signal=30%</td></tr><tr><td class='lessen'>493</td><td>JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP</td><td></td><td>46</td><td>0.19</td><td>0.88</td><td>0.634</td><td>0.869</td><td>1.000</td><td>190</td><td>tags=24%, list=15%, signal=27%</td></tr><tr><td class='lessen'>494</td><td>ZWANG_DOWN_BY_2ND_EGF_PULSE</td><td></td><td>15</td><td>0.26</td><td>0.88</td><td>0.635</td><td>0.870</td><td>1.000</td><td>46</td><td>tags=13%, list=4%, signal=14%</td></tr><tr><td class='lessen'>495</td><td>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN</td><td></td><td>23</td><td>0.23</td><td>0.88</td><td>0.626</td><td>0.868</td><td>1.000</td><td>464</td><td>tags=57%, list=37%, signal=87%</td></tr><tr><td class='lessen'>496</td><td>JIANG_HYPOXIA_NORMAL</td><td></td><td>37</td><td>0.20</td><td>0.88</td><td>0.661</td><td>0.872</td><td>1.000</td><td>117</td><td>tags=16%, list=9%, signal=17%</td></tr><tr><td class='lessen'>497</td><td>REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING</td><td></td><td>18</td><td>0.24</td><td>0.87</td><td>0.627</td><td>0.892</td><td>1.000</td><td>670</td><td>tags=78%, list=53%, signal=162%</td></tr><tr><td class='lessen'>498</td><td>MARSON_FOXP3_TARGETS_UP</td><td></td><td>22</td><td>0.23</td><td>0.86</td><td>0.662</td><td>0.899</td><td>1.000</td><td>175</td><td>tags=23%, list=14%, signal=26%</td></tr><tr><td class='lessen'>499</td><td>WINTER_HYPOXIA_UP</td><td></td><td>17</td><td>0.25</td><td>0.86</td><td>0.648</td><td>0.901</td><td>1.000</td><td>125</td><td>tags=18%, list=10%, signal=19%</td></tr><tr><td class='lessen'>500</td><td>REACTOME_NEDDYLATION</td><td></td><td>25</td><td>0.22</td><td>0.86</td><td>0.661</td><td>0.901</td><td>1.000</td><td>686</td><td>tags=76%, list=54%, signal=162%</td></tr><tr><td class='lessen'>501</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP</td><td></td><td>18</td><td>0.24</td><td>0.86</td><td>0.652</td><td>0.902</td><td>1.000</td><td>25</td><td>tags=11%, list=2%, signal=11%</td></tr><tr><td class='lessen'>502</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN</td><td></td><td>40</td><td>0.19</td><td>0.86</td><td>0.687</td><td>0.904</td><td>1.000</td><td>212</td><td>tags=23%, list=17%, signal=26%</td></tr><tr><td class='lessen'>503</td><td>REACTOME_HEDGEHOG_OFF_STATE</td><td></td><td>18</td><td>0.24</td><td>0.86</td><td>0.646</td><td>0.902</td><td>1.000</td><td>670</td><td>tags=78%, list=53%, signal=162%</td></tr><tr><td class='lessen'>504</td><td>JAEGER_METASTASIS_DN</td><td></td><td>36</td><td>0.19</td><td>0.86</td><td>0.674</td><td>0.901</td><td>1.000</td><td>333</td><td>tags=36%, list=26%, signal=48%</td></tr><tr><td class='lessen'>505</td><td>CHICAS_RB1_TARGETS_GROWING</td><td></td><td>30</td><td>0.20</td><td>0.85</td><td>0.687</td><td>0.903</td><td>1.000</td><td>455</td><td>tags=57%, list=36%, signal=86%</td></tr><tr><td class='lessen'>506</td><td>HUTTMANN_B_CLL_POOR_SURVIVAL_UP</td><td></td><td>27</td><td>0.21</td><td>0.85</td><td>0.658</td><td>0.907</td><td>1.000</td><td>75</td><td>tags=15%, list=6%, signal=15%</td></tr><tr><td class='lessen'>507</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP</td><td></td><td>19</td><td>0.23</td><td>0.85</td><td>0.675</td><td>0.907</td><td>1.000</td><td>384</td><td>tags=47%, list=30%, signal=67%</td></tr><tr><td class='lessen'>508</td><td>REACTOME_CELLULAR_SENESCENCE</td><td></td><td>15</td><td>0.25</td><td>0.85</td><td>0.676</td><td>0.907</td><td>1.000</td><td>45</td><td>tags=13%, list=4%, signal=14%</td></tr><tr><td class='lessen'>509</td><td>WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA</td><td></td><td>19</td><td>0.23</td><td>0.85</td><td>0.637</td><td>0.908</td><td>1.000</td><td>689</td><td>tags=84%, list=54%, signal=181%</td></tr><tr><td class='lessen'>510</td><td>REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS</td><td></td><td>47</td><td>0.18</td><td>0.85</td><td>0.693</td><td>0.906</td><td>1.000</td><td>670</td><td>tags=70%, list=53%, signal=143%</td></tr><tr><td class='lessen'>511</td><td>REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS</td><td></td><td>18</td><td>0.23</td><td>0.84</td><td>0.696</td><td>0.912</td><td>1.000</td><td>670</td><td>tags=78%, list=53%, signal=162%</td></tr><tr><td class='lessen'>512</td><td>RAO_BOUND_BY_SALL4_ISOFORM_B</td><td></td><td>49</td><td>0.18</td><td>0.84</td><td>0.695</td><td>0.913</td><td>1.000</td><td>348</td><td>tags=41%, list=27%, signal=54%</td></tr><tr><td class='lessen'>513</td><td>REACTOME_SIGNALING_BY_NOTCH</td><td></td><td>31</td><td>0.20</td><td>0.84</td><td>0.699</td><td>0.911</td><td>1.000</td><td>445</td><td>tags=48%, list=35%, signal=73%</td></tr><tr><td class='lessen'>514</td><td>FISCHER_G2_M_CELL_CYCLE</td><td></td><td>26</td><td>0.21</td><td>0.84</td><td>0.700</td><td>0.916</td><td>1.000</td><td>633</td><td>tags=69%, list=50%, signal=135%</td></tr><tr><td class='lessen'>515</td><td>REACTOME_HIV_INFECTION</td><td></td><td>35</td><td>0.19</td><td>0.83</td><td>0.715</td><td>0.922</td><td>1.000</td><td>397</td><td>tags=40%, list=31%, signal=57%</td></tr><tr><td class='lessen'>516</td><td>WINTER_HYPOXIA_METAGENE</td><td></td><td>51</td><td>0.17</td><td>0.83</td><td>0.741</td><td>0.922</td><td>1.000</td><td>292</td><td>tags=29%, list=23%, signal=37%</td></tr><tr><td class='lessen'>517</td><td>REACTOME_PROTEIN_LOCALIZATION</td><td></td><td>31</td><td>0.20</td><td>0.83</td><td>0.735</td><td>0.922</td><td>1.000</td><td>274</td><td>tags=32%, list=22%, signal=40%</td></tr><tr><td class='lessen'>518</td><td>LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT</td><td></td><td>16</td><td>0.24</td><td>0.83</td><td>0.660</td><td>0.924</td><td>1.000</td><td>229</td><td>tags=31%, list=18%, signal=38%</td></tr><tr><td class='lessen'>519</td><td>REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION</td><td></td><td>120</td><td>0.15</td><td>0.83</td><td>0.816</td><td>0.923</td><td>1.000</td><td>414</td><td>tags=38%, list=33%, signal=51%</td></tr><tr><td class='lessen'>520</td><td>HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN</td><td></td><td>17</td><td>0.23</td><td>0.83</td><td>0.702</td><td>0.928</td><td>1.000</td><td>475</td><td>tags=53%, list=37%, signal=83%</td></tr><tr><td class='lessen'>521</td><td>SEIDEN_ONCOGENESIS_BY_MET</td><td></td><td>20</td><td>0.22</td><td>0.83</td><td>0.691</td><td>0.927</td><td>1.000</td><td>217</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>522</td><td>ALFANO_MYC_TARGETS</td><td></td><td>38</td><td>0.18</td><td>0.82</td><td>0.741</td><td>0.927</td><td>1.000</td><td>538</td><td>tags=63%, list=42%, signal=106%</td></tr><tr><td class='lessen'>523</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP</td><td></td><td>18</td><td>0.23</td><td>0.82</td><td>0.679</td><td>0.926</td><td>1.000</td><td>197</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>524</td><td>SENESE_HDAC1_AND_HDAC2_TARGETS_DN</td><td></td><td>22</td><td>0.21</td><td>0.82</td><td>0.708</td><td>0.926</td><td>1.000</td><td>142</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>525</td><td>WP_MESODERMAL_COMMITMENT_PATHWAY</td><td></td><td>15</td><td>0.25</td><td>0.82</td><td>0.688</td><td>0.927</td><td>1.000</td><td>313</td><td>tags=40%, list=25%, signal=52%</td></tr><tr><td class='lessen'>526</td><td>WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY</td><td></td><td>19</td><td>0.22</td><td>0.82</td><td>0.706</td><td>0.932</td><td>1.000</td><td>376</td><td>tags=42%, list=30%, signal=59%</td></tr><tr><td class='lessen'>527</td><td>AMIT_EGF_RESPONSE_120_HELA</td><td></td><td>15</td><td>0.24</td><td>0.82</td><td>0.711</td><td>0.931</td><td>1.000</td><td>267</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>528</td><td>REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53</td><td></td><td>46</td><td>0.17</td><td>0.81</td><td>0.772</td><td>0.933</td><td>1.000</td><td>405</td><td>tags=43%, list=32%, signal=62%</td></tr><tr><td class='lessen'>529</td><td>REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR_</td><td></td><td>18</td><td>0.22</td><td>0.81</td><td>0.722</td><td>0.935</td><td>1.000</td><td>71</td><td>tags=11%, list=6%, signal=12%</td></tr><tr><td class='lessen'>530</td><td>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN</td><td></td><td>16</td><td>0.24</td><td>0.81</td><td>0.724</td><td>0.936</td><td>1.000</td><td>190</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>531</td><td>PID_BETA_CATENIN_NUC_PATHWAY</td><td></td><td>16</td><td>0.24</td><td>0.81</td><td>0.708</td><td>0.939</td><td>1.000</td><td>370</td><td>tags=50%, list=29%, signal=70%</td></tr><tr><td class='lessen'>532</td><td>REACTOME_S_PHASE</td><td></td><td>26</td><td>0.20</td><td>0.80</td><td>0.742</td><td>0.946</td><td>1.000</td><td>670</td><td>tags=77%, list=53%, signal=159%</td></tr><tr><td class='lessen'>533</td><td>LEE_AGING_NEOCORTEX_UP</td><td></td><td>19</td><td>0.22</td><td>0.80</td><td>0.708</td><td>0.951</td><td>1.000</td><td>82</td><td>tags=16%, list=6%, signal=17%</td></tr><tr><td class='lessen'>534</td><td>REACTOME_ORC1_REMOVAL_FROM_CHROMATIN</td><td></td><td>17</td><td>0.22</td><td>0.80</td><td>0.727</td><td>0.953</td><td>1.000</td><td>670</td><td>tags=76%, list=53%, signal=160%</td></tr><tr><td class='lessen'>535</td><td>WANG_CLIM2_TARGETS_DN</td><td></td><td>20</td><td>0.21</td><td>0.79</td><td>0.732</td><td>0.955</td><td>1.000</td><td>170</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>536</td><td>LAIHO_COLORECTAL_CANCER_SERRATED_UP</td><td></td><td>35</td><td>0.18</td><td>0.79</td><td>0.770</td><td>0.953</td><td>1.000</td><td>452</td><td>tags=51%, list=36%, signal=78%</td></tr><tr><td class='lessen'>537</td><td>LIM_MAMMARY_STEM_CELL_DN</td><td></td><td>53</td><td>0.16</td><td>0.79</td><td>0.786</td><td>0.955</td><td>1.000</td><td>270</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>538</td><td>REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS</td><td></td><td>17</td><td>0.23</td><td>0.79</td><td>0.733</td><td>0.953</td><td>1.000</td><td>670</td><td>tags=76%, list=53%, signal=160%</td></tr><tr><td class='lessen'>539</td><td>HATADA_METHYLATED_IN_LUNG_CANCER_UP</td><td></td><td>18</td><td>0.22</td><td>0.79</td><td>0.754</td><td>0.953</td><td>1.000</td><td>96</td><td>tags=17%, list=8%, signal=18%</td></tr><tr><td class='lessen'>540</td><td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP</td><td></td><td>18</td><td>0.22</td><td>0.79</td><td>0.736</td><td>0.957</td><td>1.000</td><td>644</td><td>tags=72%, list=51%, signal=144%</td></tr><tr><td class='lessen'>541</td><td>REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1</td><td></td><td>17</td><td>0.22</td><td>0.79</td><td>0.748</td><td>0.959</td><td>1.000</td><td>670</td><td>tags=76%, list=53%, signal=160%</td></tr><tr><td class='lessen'>542</td><td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN</td><td></td><td>50</td><td>0.17</td><td>0.79</td><td>0.780</td><td>0.957</td><td>1.000</td><td>345</td><td>tags=34%, list=27%, signal=45%</td></tr><tr><td class='lessen'>543</td><td>REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR_</td><td></td><td>18</td><td>0.22</td><td>0.78</td><td>0.767</td><td>0.960</td><td>1.000</td><td>71</td><td>tags=11%, list=6%, signal=12%</td></tr><tr><td class='lessen'>544</td><td>KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES</td><td></td><td>19</td><td>0.21</td><td>0.78</td><td>0.747</td><td>0.963</td><td>1.000</td><td>0</td><td>tags=5%, list=0%, signal=5%</td></tr><tr><td class='lessen'>545</td><td>HOLLERN_EMT_BREAST_TUMOR_DN</td><td></td><td>24</td><td>0.20</td><td>0.77</td><td>0.765</td><td>0.969</td><td>1.000</td><td>395</td><td>tags=42%, list=31%, signal=59%</td></tr><tr><td class='lessen'>546</td><td>MOOTHA_VOXPHOS</td><td></td><td>18</td><td>0.22</td><td>0.77</td><td>0.755</td><td>0.972</td><td>1.000</td><td>689</td><td>tags=83%, list=54%, signal=179%</td></tr><tr><td class='lessen'>547</td><td>TSENG_IRS1_TARGETS_UP</td><td></td><td>20</td><td>0.21</td><td>0.76</td><td>0.755</td><td>0.979</td><td>1.000</td><td>443</td><td>tags=50%, list=35%, signal=76%</td></tr><tr><td class='lessen'>548</td><td>PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN</td><td></td><td>20</td><td>0.21</td><td>0.76</td><td>0.774</td><td>0.979</td><td>1.000</td><td>329</td><td>tags=40%, list=26%, signal=53%</td></tr><tr><td class='lessen'>549</td><td>WP_ADIPOGENESIS</td><td></td><td>17</td><td>0.22</td><td>0.76</td><td>0.745</td><td>0.979</td><td>1.000</td><td>147</td><td>tags=18%, list=12%, signal=20%</td></tr><tr><td class='lessen'>550</td><td>LEE_NEURAL_CREST_STEM_CELL_DN</td><td></td><td>16</td><td>0.22</td><td>0.76</td><td>0.735</td><td>0.978</td><td>1.000</td><td>127</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>551</td><td>DURCHDEWALD_SKIN_CARCINOGENESIS_DN</td><td></td><td>35</td><td>0.17</td><td>0.76</td><td>0.803</td><td>0.977</td><td>1.000</td><td>292</td><td>tags=31%, list=23%, signal=40%</td></tr><tr><td class='lessen'>552</td><td>REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES</td><td></td><td>58</td><td>0.16</td><td>0.76</td><td>0.863</td><td>0.976</td><td>1.000</td><td>268</td><td>tags=28%, list=21%, signal=33%</td></tr><tr><td class='lessen'>553</td><td>REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION</td><td></td><td>27</td><td>0.19</td><td>0.76</td><td>0.804</td><td>0.975</td><td>1.000</td><td>670</td><td>tags=74%, list=53%, signal=153%</td></tr><tr><td class='lessen'>554</td><td>ZHENG_FOXP3_TARGETS_IN_THYMUS_UP</td><td></td><td>22</td><td>0.20</td><td>0.76</td><td>0.786</td><td>0.978</td><td>1.000</td><td>1019</td><td>tags=100%, list=80%, signal=496%</td></tr><tr><td class='lessen'>555</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_P3</td><td></td><td>19</td><td>0.20</td><td>0.75</td><td>0.785</td><td>0.980</td><td>1.000</td><td>193</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>556</td><td>REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS</td><td></td><td>15</td><td>0.22</td><td>0.75</td><td>0.766</td><td>0.980</td><td>1.000</td><td>268</td><td>tags=27%, list=21%, signal=33%</td></tr><tr><td class='lessen'>557</td><td>MCCABE_BOUND_BY_HOXC6</td><td></td><td>21</td><td>0.19</td><td>0.75</td><td>0.796</td><td>0.980</td><td>1.000</td><td>108</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>558</td><td>UEDA_PERIFERAL_CLOCK</td><td></td><td>33</td><td>0.17</td><td>0.75</td><td>0.820</td><td>0.980</td><td>1.000</td><td>285</td><td>tags=30%, list=22%, signal=38%</td></tr><tr><td class='lessen'>559</td><td>ZHENG_BOUND_BY_FOXP3</td><td></td><td>34</td><td>0.17</td><td>0.75</td><td>0.823</td><td>0.981</td><td>1.000</td><td>58</td><td>tags=9%, list=5%, signal=9%</td></tr><tr><td class='lessen'>560</td><td>REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION</td><td></td><td>17</td><td>0.22</td><td>0.75</td><td>0.790</td><td>0.982</td><td>1.000</td><td>676</td><td>tags=76%, list=53%, signal=161%</td></tr><tr><td class='lessen'>561</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN</td><td></td><td>35</td><td>0.17</td><td>0.74</td><td>0.829</td><td>0.988</td><td>1.000</td><td>237</td><td>tags=23%, list=19%, signal=27%</td></tr><tr><td class='lessen'>562</td><td>MCBRYAN_PUBERTAL_BREAST_5_6WK_DN</td><td></td><td>25</td><td>0.19</td><td>0.74</td><td>0.815</td><td>0.987</td><td>1.000</td><td>240</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>563</td><td>REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION</td><td></td><td>26</td><td>0.18</td><td>0.74</td><td>0.823</td><td>0.985</td><td>1.000</td><td>686</td><td>tags=73%, list=54%, signal=156%</td></tr><tr><td class='lessen'>564</td><td>REACTOME_REGULATION_OF_RAS_BY_GAPS</td><td></td><td>16</td><td>0.21</td><td>0.74</td><td>0.773</td><td>0.985</td><td>1.000</td><td>670</td><td>tags=75%, list=53%, signal=157%</td></tr><tr><td class='lessen'>565</td><td>REACTOME_DEGRADATION_OF_DVL</td><td></td><td>16</td><td>0.21</td><td>0.74</td><td>0.811</td><td>0.987</td><td>1.000</td><td>670</td><td>tags=75%, list=53%, signal=157%</td></tr><tr><td class='lessen'>566</td><td>CAIRO_LIVER_DEVELOPMENT_UP</td><td></td><td>17</td><td>0.21</td><td>0.74</td><td>0.793</td><td>0.986</td><td>1.000</td><td>316</td><td>tags=41%, list=25%, signal=54%</td></tr><tr><td class='lessen'>567</td><td>DOANE_BREAST_CANCER_ESR1_UP</td><td></td><td>16</td><td>0.21</td><td>0.73</td><td>0.789</td><td>0.989</td><td>1.000</td><td>167</td><td>tags=19%, list=13%, signal=21%</td></tr><tr><td class='lessen'>568</td><td>REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME</td><td></td><td>16</td><td>0.21</td><td>0.73</td><td>0.811</td><td>0.989</td><td>1.000</td><td>670</td><td>tags=75%, list=53%, signal=157%</td></tr><tr><td class='lessen'>569</td><td>KYNG_DNA_DAMAGE_UP</td><td></td><td>25</td><td>0.18</td><td>0.73</td><td>0.834</td><td>0.989</td><td>1.000</td><td>592</td><td>tags=64%, list=47%, signal=117%</td></tr><tr><td class='lessen'>570</td><td>LI_DCP2_BOUND_MRNA</td><td></td><td>16</td><td>0.21</td><td>0.73</td><td>0.814</td><td>0.992</td><td>1.000</td><td>595</td><td>tags=75%, list=47%, signal=139%</td></tr><tr><td class='lessen'>571</td><td>REACTOME_UCH_PROTEINASES</td><td></td><td>16</td><td>0.21</td><td>0.72</td><td>0.829</td><td>0.993</td><td>1.000</td><td>670</td><td>tags=75%, list=53%, signal=157%</td></tr><tr><td class='lessen'>572</td><td>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP</td><td></td><td>23</td><td>0.19</td><td>0.72</td><td>0.832</td><td>0.994</td><td>1.000</td><td>33</td><td>tags=9%, list=3%, signal=9%</td></tr><tr><td class='lessen'>573</td><td>REACTOME_DNA_REPLICATION_PRE_INITIATION</td><td></td><td>16</td><td>0.21</td><td>0.72</td><td>0.823</td><td>0.994</td><td>1.000</td><td>670</td><td>tags=75%, list=53%, signal=157%</td></tr><tr><td class='lessen'>574</td><td>CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP</td><td></td><td>28</td><td>0.18</td><td>0.72</td><td>0.849</td><td>0.995</td><td>1.000</td><td>241</td><td>tags=25%, list=19%, signal=30%</td></tr><tr><td class='lessen'>575</td><td>RICKMAN_METASTASIS_UP</td><td></td><td>20</td><td>0.19</td><td>0.71</td><td>0.829</td><td>0.996</td><td>1.000</td><td>50</td><td>tags=10%, list=4%, signal=10%</td></tr><tr><td class='lessen'>576</td><td>REACTOME_HEDGEHOG_ON_STATE</td><td></td><td>16</td><td>0.21</td><td>0.71</td><td>0.803</td><td>0.994</td><td>1.000</td><td>670</td><td>tags=75%, list=53%, signal=157%</td></tr><tr><td class='lessen'>577</td><td>KEGG_HUNTINGTONS_DISEASE</td><td></td><td>28</td><td>0.18</td><td>0.71</td><td>0.826</td><td>0.994</td><td>1.000</td><td>437</td><td>tags=46%, list=34%, signal=69%</td></tr><tr><td class='lessen'>578</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP</td><td></td><td>48</td><td>0.15</td><td>0.71</td><td>0.880</td><td>0.993</td><td>1.000</td><td>475</td><td>tags=50%, list=37%, signal=77%</td></tr><tr><td class='lessen'>579</td><td>COLDREN_GEFITINIB_RESISTANCE_DN</td><td></td><td>39</td><td>0.16</td><td>0.71</td><td>0.883</td><td>0.993</td><td>1.000</td><td>233</td><td>tags=23%, list=18%, signal=27%</td></tr><tr><td class='lessen'>580</td><td>KEGG_PARKINSONS_DISEASE</td><td></td><td>23</td><td>0.19</td><td>0.70</td><td>0.830</td><td>0.999</td><td>1.000</td><td>534</td><td>tags=61%, list=42%, signal=103%</td></tr><tr><td class='lessen'>581</td><td>MOOTHA_HUMAN_MITODB_6_2002</td><td></td><td>68</td><td>0.14</td><td>0.70</td><td>0.900</td><td>0.997</td><td>1.000</td><td>428</td><td>tags=40%, list=34%, signal=57%</td></tr><tr><td class='lessen'>582</td><td>REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS</td><td></td><td>15</td><td>0.20</td><td>0.70</td><td>0.829</td><td>0.996</td><td>1.000</td><td>15</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>583</td><td>OSMAN_BLADDER_CANCER_UP</td><td></td><td>48</td><td>0.15</td><td>0.70</td><td>0.862</td><td>0.997</td><td>1.000</td><td>408</td><td>tags=40%, list=32%, signal=56%</td></tr><tr><td class='lessen'>584</td><td>WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY</td><td></td><td>16</td><td>0.20</td><td>0.70</td><td>0.811</td><td>0.996</td><td>1.000</td><td>405</td><td>tags=44%, list=32%, signal=63%</td></tr><tr><td class='lessen'>585</td><td>WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP</td><td></td><td>66</td><td>0.14</td><td>0.70</td><td>0.897</td><td>0.995</td><td>1.000</td><td>244</td><td>tags=21%, list=19%, signal=25%</td></tr><tr><td class='lessen'>586</td><td>DOUGLAS_BMI1_TARGETS_DN</td><td></td><td>23</td><td>0.18</td><td>0.70</td><td>0.864</td><td>0.997</td><td>1.000</td><td>44</td><td>tags=9%, list=3%, signal=9%</td></tr><tr><td class='lessen'>587</td><td>KAAB_FAILED_HEART_ATRIUM_DN</td><td></td><td>33</td><td>0.16</td><td>0.70</td><td>0.876</td><td>0.996</td><td>1.000</td><td>484</td><td>tags=48%, list=38%, signal=76%</td></tr><tr><td class='lessen'>588</td><td>OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP</td><td></td><td>20</td><td>0.19</td><td>0.69</td><td>0.878</td><td>0.997</td><td>1.000</td><td>506</td><td>tags=55%, list=40%, signal=90%</td></tr><tr><td class='lessen'>589</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3</td><td></td><td>47</td><td>0.15</td><td>0.69</td><td>0.890</td><td>0.997</td><td>1.000</td><td>293</td><td>tags=28%, list=23%, signal=35%</td></tr><tr><td class='lessen'>590</td><td>REACTOME_DEGRADATION_OF_AXIN</td><td></td><td>15</td><td>0.20</td><td>0.69</td><td>0.821</td><td>0.996</td><td>1.000</td><td>15</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>591</td><td>BAKKER_FOXO3_TARGETS_DN</td><td></td><td>18</td><td>0.19</td><td>0.69</td><td>0.850</td><td>0.995</td><td>1.000</td><td>283</td><td>tags=33%, list=22%, signal=42%</td></tr><tr><td class='lessen'>592</td><td>REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING</td><td></td><td>15</td><td>0.20</td><td>0.69</td><td>0.865</td><td>0.995</td><td>1.000</td><td>15</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>593</td><td>EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP</td><td></td><td>25</td><td>0.17</td><td>0.69</td><td>0.876</td><td>0.994</td><td>1.000</td><td>141</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>594</td><td>YAGI_AML_FAB_MARKERS</td><td></td><td>22</td><td>0.18</td><td>0.69</td><td>0.858</td><td>0.993</td><td>1.000</td><td>1047</td><td>tags=100%, list=82%, signal=558%</td></tr><tr><td class='lessen'>595</td><td>REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY</td><td></td><td>15</td><td>0.20</td><td>0.69</td><td>0.849</td><td>0.993</td><td>1.000</td><td>15</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>596</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN</td><td></td><td>29</td><td>0.17</td><td>0.68</td><td>0.861</td><td>0.994</td><td>1.000</td><td>75</td><td>tags=10%, list=6%, signal=11%</td></tr><tr><td class='lessen'>597</td><td>REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS</td><td></td><td>15</td><td>0.20</td><td>0.68</td><td>0.841</td><td>0.992</td><td>1.000</td><td>268</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>598</td><td>REACTOME_STABILIZATION_OF_P53</td><td></td><td>15</td><td>0.20</td><td>0.68</td><td>0.841</td><td>0.993</td><td>1.000</td><td>15</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>599</td><td>WANG_TUMOR_INVASIVENESS_DN</td><td></td><td>37</td><td>0.15</td><td>0.68</td><td>0.888</td><td>0.993</td><td>1.000</td><td>368</td><td>tags=38%, list=29%, signal=52%</td></tr><tr><td class='lessen'>600</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_DN</td><td></td><td>59</td><td>0.14</td><td>0.68</td><td>0.915</td><td>0.993</td><td>1.000</td><td>843</td><td>tags=85%, list=66%, signal=240%</td></tr><tr><td class='lessen'>601</td><td>REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX</td><td></td><td>15</td><td>0.20</td><td>0.68</td><td>0.867</td><td>0.992</td><td>1.000</td><td>15</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>602</td><td>MOHANKUMAR_HOXA1_TARGETS_UP</td><td></td><td>51</td><td>0.14</td><td>0.67</td><td>0.902</td><td>0.997</td><td>1.000</td><td>458</td><td>tags=41%, list=36%, signal=62%</td></tr><tr><td class='lessen'>603</td><td>VERHAAK_GLIOBLASTOMA_MESENCHYMAL</td><td></td><td>26</td><td>0.17</td><td>0.67</td><td>0.871</td><td>0.996</td><td>1.000</td><td>1062</td><td>tags=100%, list=84%, signal=596%</td></tr><tr><td class='lessen'>604</td><td>MOOTHA_MITOCHONDRIA</td><td></td><td>69</td><td>0.13</td><td>0.67</td><td>0.911</td><td>0.994</td><td>1.000</td><td>428</td><td>tags=39%, list=34%, signal=56%</td></tr><tr><td class='lessen'>605</td><td>MIKKELSEN_NPC_ICP_WITH_H3K4ME3</td><td></td><td>26</td><td>0.17</td><td>0.67</td><td>0.879</td><td>0.993</td><td>1.000</td><td>293</td><td>tags=31%, list=23%, signal=39%</td></tr><tr><td class='lessen'>606</td><td>REACTOME_PCP_CE_PATHWAY</td><td></td><td>16</td><td>0.19</td><td>0.66</td><td>0.870</td><td>0.995</td><td>1.000</td><td>15</td><td>tags=6%, list=1%, signal=6%</td></tr><tr><td class='lessen'>607</td><td>BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN</td><td></td><td>19</td><td>0.18</td><td>0.66</td><td>0.889</td><td>0.994</td><td>1.000</td><td>293</td><td>tags=32%, list=23%, signal=40%</td></tr><tr><td class='lessen'>608</td><td>REACTOME_SIGNALING_BY_HEDGEHOG</td><td></td><td>20</td><td>0.18</td><td>0.66</td><td>0.907</td><td>0.996</td><td>1.000</td><td>670</td><td>tags=75%, list=53%, signal=156%</td></tr><tr><td class='lessen'>609</td><td>FORTSCHEGGER_PHF8_TARGETS_UP</td><td></td><td>29</td><td>0.16</td><td>0.66</td><td>0.910</td><td>0.997</td><td>1.000</td><td>81</td><td>tags=10%, list=6%, signal=11%</td></tr><tr><td class='lessen'>610</td><td>OKUMURA_INFLAMMATORY_RESPONSE_LPS</td><td></td><td>24</td><td>0.17</td><td>0.65</td><td>0.881</td><td>0.998</td><td>1.000</td><td>216</td><td>tags=21%, list=17%, signal=25%</td></tr><tr><td class='lessen'>611</td><td>MULLIGHAN_MLL_SIGNATURE_1_UP</td><td></td><td>30</td><td>0.16</td><td>0.65</td><td>0.897</td><td>1.000</td><td>1.000</td><td>246</td><td>tags=20%, list=19%, signal=24%</td></tr><tr><td class='lessen'>612</td><td>DITTMER_PTHLH_TARGETS_UP</td><td></td><td>30</td><td>0.16</td><td>0.65</td><td>0.913</td><td>1.000</td><td>1.000</td><td>240</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>613</td><td>REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY</td><td></td><td>17</td><td>0.19</td><td>0.64</td><td>0.870</td><td>1.000</td><td>1.000</td><td>15</td><td>tags=6%, list=1%, signal=6%</td></tr><tr><td class='lessen'>614</td><td>LIAO_METASTASIS</td><td></td><td>51</td><td>0.13</td><td>0.64</td><td>0.929</td><td>0.999</td><td>1.000</td><td>273</td><td>tags=24%, list=21%, signal=29%</td></tr><tr><td class='lessen'>615</td><td>REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21</td><td></td><td>19</td><td>0.17</td><td>0.64</td><td>0.889</td><td>0.999</td><td>1.000</td><td>670</td><td>tags=74%, list=53%, signal=153%</td></tr><tr><td class='lessen'>616</td><td>REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS</td><td></td><td>17</td><td>0.18</td><td>0.63</td><td>0.892</td><td>1.000</td><td>1.000</td><td>15</td><td>tags=6%, list=1%, signal=6%</td></tr><tr><td class='lessen'>617</td><td>FARMER_BREAST_CANCER_BASAL_VS_LULMINAL</td><td></td><td>47</td><td>0.13</td><td>0.63</td><td>0.936</td><td>1.000</td><td>1.000</td><td>322</td><td>tags=30%, list=25%, signal=38%</td></tr><tr><td class='lessen'>618</td><td>KRIEG_HYPOXIA_NOT_VIA_KDM3A</td><td></td><td>86</td><td>0.12</td><td>0.62</td><td>0.970</td><td>1.000</td><td>1.000</td><td>265</td><td>tags=22%, list=21%, signal=26%</td></tr><tr><td class='lessen'>619</td><td>MARSON_BOUND_BY_FOXP3_STIMULATED</td><td></td><td>100</td><td>0.11</td><td>0.62</td><td>0.960</td><td>1.000</td><td>1.000</td><td>45</td><td>tags=5%, list=4%, signal=5%</td></tr><tr><td class='lessen'>620</td><td>ONKEN_UVEAL_MELANOMA_UP</td><td></td><td>101</td><td>0.11</td><td>0.62</td><td>0.982</td><td>1.000</td><td>1.000</td><td>504</td><td>tags=47%, list=40%, signal=71%</td></tr><tr><td class='lessen'>621</td><td>REACTOME_TCR_SIGNALING</td><td></td><td>19</td><td>0.17</td><td>0.62</td><td>0.898</td><td>1.000</td><td>1.000</td><td>688</td><td>tags=74%, list=54%, signal=158%</td></tr><tr><td class='lessen'>622</td><td>WP_CALCIUM_REGULATION_IN_THE_CARDIAC_CELL</td><td></td><td>16</td><td>0.18</td><td>0.62</td><td>0.895</td><td>1.000</td><td>1.000</td><td>290</td><td>tags=38%, list=23%, signal=48%</td></tr><tr><td class='lessen'>623</td><td>REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY</td><td></td><td>19</td><td>0.17</td><td>0.62</td><td>0.903</td><td>1.000</td><td>1.000</td><td>15</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>624</td><td>PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP</td><td></td><td>15</td><td>0.18</td><td>0.62</td><td>0.922</td><td>1.000</td><td>1.000</td><td>572</td><td>tags=67%, list=45%, signal=120%</td></tr><tr><td class='lessen'>625</td><td>REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY</td><td></td><td>19</td><td>0.17</td><td>0.61</td><td>0.915</td><td>1.000</td><td>1.000</td><td>670</td><td>tags=68%, list=53%, signal=143%</td></tr><tr><td class='lessen'>626</td><td>RIZKI_TUMOR_INVASIVENESS_3D_DN</td><td></td><td>31</td><td>0.15</td><td>0.61</td><td>0.945</td><td>1.000</td><td>1.000</td><td>199</td><td>tags=19%, list=16%, signal=22%</td></tr><tr><td class='lessen'>627</td><td>DELACROIX_RARG_BOUND_MEF</td><td></td><td>46</td><td>0.13</td><td>0.61</td><td>0.938</td><td>1.000</td><td>1.000</td><td>288</td><td>tags=26%, list=23%, signal=33%</td></tr><tr><td class='lessen'>628</td><td>REACTOME_SIGNALING_BY_WNT</td><td></td><td>33</td><td>0.14</td><td>0.60</td><td>0.933</td><td>1.000</td><td>1.000</td><td>45</td><td>tags=6%, list=4%, signal=6%</td></tr><tr><td class='lessen'>629</td><td>REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT</td><td></td><td>31</td><td>0.14</td><td>0.60</td><td>0.941</td><td>1.000</td><td>1.000</td><td>689</td><td>tags=71%, list=54%, signal=151%</td></tr><tr><td class='lessen'>630</td><td>REN_ALVEOLAR_RHABDOMYOSARCOMA_DN</td><td></td><td>64</td><td>0.12</td><td>0.60</td><td>0.975</td><td>1.000</td><td>1.000</td><td>212</td><td>tags=16%, list=17%, signal=18%</td></tr><tr><td class='lessen'>631</td><td>REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY</td><td></td><td>22</td><td>0.16</td><td>0.60</td><td>0.920</td><td>1.000</td><td>1.000</td><td>670</td><td>tags=73%, list=53%, signal=151%</td></tr><tr><td class='lessen'>632</td><td>MASSARWEH_TAMOXIFEN_RESISTANCE_DN</td><td></td><td>26</td><td>0.15</td><td>0.59</td><td>0.950</td><td>1.000</td><td>1.000</td><td>515</td><td>tags=54%, list=41%, signal=89%</td></tr><tr><td class='lessen'>633</td><td>REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3</td><td></td><td>20</td><td>0.16</td><td>0.59</td><td>0.932</td><td>1.000</td><td>1.000</td><td>708</td><td>tags=75%, list=56%, signal=167%</td></tr><tr><td class='lessen'>634</td><td>REACTOME_MAPK6_MAPK4_SIGNALING</td><td></td><td>17</td><td>0.17</td><td>0.59</td><td>0.927</td><td>1.000</td><td>1.000</td><td>15</td><td>tags=6%, list=1%, signal=6%</td></tr><tr><td class='lessen'>635</td><td>IGARASHI_ATF4_TARGETS_DN</td><td></td><td>17</td><td>0.16</td><td>0.59</td><td>0.918</td><td>1.000</td><td>1.000</td><td>14</td><td>tags=6%, list=1%, signal=6%</td></tr><tr><td class='lessen'>636</td><td>REACTOME_HEDGEHOG_LIGAND_BIOGENESIS</td><td></td><td>17</td><td>0.17</td><td>0.59</td><td>0.929</td><td>1.000</td><td>1.000</td><td>15</td><td>tags=6%, list=1%, signal=6%</td></tr><tr><td class='lessen'>637</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP</td><td></td><td>16</td><td>0.17</td><td>0.58</td><td>0.942</td><td>1.000</td><td>1.000</td><td>117</td><td>tags=13%, list=9%, signal=14%</td></tr><tr><td class='lessen'>638</td><td>PLASARI_TGFB1_TARGETS_10HR_DN</td><td></td><td>22</td><td>0.15</td><td>0.57</td><td>0.941</td><td>1.000</td><td>1.000</td><td>118</td><td>tags=14%, list=9%, signal=15%</td></tr><tr><td class='lessen'>639</td><td>REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX</td><td></td><td>20</td><td>0.16</td><td>0.57</td><td>0.943</td><td>1.000</td><td>1.000</td><td>15</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>640</td><td>NUYTTEN_NIPP1_TARGETS_UP</td><td></td><td>56</td><td>0.12</td><td>0.57</td><td>0.980</td><td>1.000</td><td>1.000</td><td>354</td><td>tags=32%, list=28%, signal=43%</td></tr><tr><td class='lessen'>641</td><td>BLUM_RESPONSE_TO_SALIRASIB_UP</td><td></td><td>26</td><td>0.14</td><td>0.57</td><td>0.964</td><td>1.000</td><td>1.000</td><td>117</td><td>tags=12%, list=9%, signal=12%</td></tr><tr><td class='lessen'>642</td><td>REACTOME_REGULATION_OF_TP53_ACTIVITY</td><td></td><td>15</td><td>0.17</td><td>0.57</td><td>0.944</td><td>1.000</td><td>1.000</td><td>15</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>643</td><td>REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA</td><td></td><td>19</td><td>0.16</td><td>0.56</td><td>0.945</td><td>1.000</td><td>1.000</td><td>15</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>644</td><td>REACTOME_CLEC7A_DECTIN_1_SIGNALING</td><td></td><td>20</td><td>0.15</td><td>0.56</td><td>0.948</td><td>1.000</td><td>1.000</td><td>15</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>645</td><td>YANG_BCL3_TARGETS_UP</td><td></td><td>42</td><td>0.12</td><td>0.56</td><td>0.963</td><td>1.000</td><td>1.000</td><td>140</td><td>tags=12%, list=11%, signal=13%</td></tr><tr><td class='lessen'>646</td><td>WANG_LMO4_TARGETS_DN</td><td></td><td>31</td><td>0.13</td><td>0.56</td><td>0.973</td><td>1.000</td><td>1.000</td><td>355</td><td>tags=32%, list=28%, signal=44%</td></tr><tr><td class='lessen'>647</td><td>BAELDE_DIABETIC_NEPHROPATHY_DN</td><td></td><td>64</td><td>0.11</td><td>0.55</td><td>0.995</td><td>1.000</td><td>1.000</td><td>372</td><td>tags=33%, list=29%, signal=44%</td></tr><tr><td class='lessen'>648</td><td>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN</td><td></td><td>61</td><td>0.11</td><td>0.55</td><td>0.984</td><td>1.000</td><td>1.000</td><td>509</td><td>tags=51%, list=40%, signal=81%</td></tr><tr><td class='lessen'>649</td><td>WANG_LMO4_TARGETS_UP</td><td></td><td>52</td><td>0.12</td><td>0.55</td><td>0.970</td><td>0.999</td><td>1.000</td><td>474</td><td>tags=40%, list=37%, signal=62%</td></tr><tr><td class='lessen'>650</td><td>REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING</td><td></td><td>21</td><td>0.14</td><td>0.55</td><td>0.956</td><td>0.998</td><td>1.000</td><td>15</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>651</td><td>ALCALAY_AML_BY_NPM1_LOCALIZATION_DN</td><td></td><td>27</td><td>0.14</td><td>0.55</td><td>0.964</td><td>0.999</td><td>1.000</td><td>293</td><td>tags=26%, list=23%, signal=33%</td></tr><tr><td class='lessen'>652</td><td>MCBRYAN_PUBERTAL_BREAST_6_7WK_UP</td><td></td><td>30</td><td>0.13</td><td>0.54</td><td>0.970</td><td>1.000</td><td>1.000</td><td>378</td><td>tags=33%, list=30%, signal=46%</td></tr><tr><td class='lessen'>653</td><td>AMIT_EGF_RESPONSE_480_HELA</td><td></td><td>32</td><td>0.13</td><td>0.53</td><td>0.960</td><td>1.000</td><td>1.000</td><td>267</td><td>tags=22%, list=21%, signal=27%</td></tr><tr><td class='lessen'>654</td><td>DARWICHE_PAPILLOMA_RISK_HIGH_DN</td><td></td><td>17</td><td>0.15</td><td>0.53</td><td>0.970</td><td>1.000</td><td>1.000</td><td>126</td><td>tags=12%, list=10%, signal=13%</td></tr><tr><td class='lessen'>655</td><td>REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2</td><td></td><td>28</td><td>0.13</td><td>0.52</td><td>0.974</td><td>1.000</td><td>1.000</td><td>397</td><td>tags=36%, list=31%, signal=51%</td></tr><tr><td class='lessen'>656</td><td>SENESE_HDAC3_TARGETS_UP</td><td></td><td>49</td><td>0.11</td><td>0.52</td><td>0.986</td><td>1.000</td><td>1.000</td><td>1136</td><td>tags=100%, list=89%, signal=905%</td></tr><tr><td class='lessen'>657</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D</td><td></td><td>65</td><td>0.10</td><td>0.52</td><td>0.995</td><td>1.000</td><td>1.000</td><td>282</td><td>tags=22%, list=22%, signal=26%</td></tr><tr><td class='lessen'>658</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_T4</td><td></td><td>15</td><td>0.15</td><td>0.52</td><td>0.965</td><td>0.999</td><td>1.000</td><td>409</td><td>tags=40%, list=32%, signal=58%</td></tr><tr><td class='lessen'>659</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM</td><td></td><td>20</td><td>0.14</td><td>0.51</td><td>0.969</td><td>0.999</td><td>1.000</td><td>478</td><td>tags=45%, list=38%, signal=71%</td></tr><tr><td class='lessen'>660</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN</td><td></td><td>77</td><td>0.10</td><td>0.51</td><td>0.993</td><td>0.999</td><td>1.000</td><td>338</td><td>tags=29%, list=27%, signal=37%</td></tr><tr><td class='lessen'>661</td><td>REACTOME_MEMBRANE_TRAFFICKING</td><td></td><td>54</td><td>0.11</td><td>0.51</td><td>0.991</td><td>0.998</td><td>1.000</td><td>429</td><td>tags=39%, list=34%, signal=56%</td></tr><tr><td class='lessen'>662</td><td>FOSTER_KDM1A_TARGETS_DN</td><td></td><td>20</td><td>0.14</td><td>0.50</td><td>0.969</td><td>0.998</td><td>1.000</td><td>1100</td><td>tags=100%, list=87%, signal=732%</td></tr><tr><td class='lessen'>663</td><td>ROZANOV_MMP14_TARGETS_UP</td><td></td><td>29</td><td>0.12</td><td>0.49</td><td>0.978</td><td>0.998</td><td>1.000</td><td>415</td><td>tags=41%, list=33%, signal=60%</td></tr><tr><td class='lessen'>664</td><td>TOOKER_GEMCITABINE_RESISTANCE_DN</td><td></td><td>28</td><td>0.12</td><td>0.49</td><td>0.986</td><td>0.997</td><td>1.000</td><td>345</td><td>tags=29%, list=27%, signal=38%</td></tr><tr><td class='lessen'>665</td><td>REACTOME_FLT3_SIGNALING</td><td></td><td>35</td><td>0.11</td><td>0.48</td><td>0.988</td><td>0.998</td><td>1.000</td><td>1132</td><td>tags=100%, list=89%, signal=889%</td></tr><tr><td class='lessen'>666</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN</td><td></td><td>35</td><td>0.11</td><td>0.48</td><td>0.990</td><td>0.996</td><td>1.000</td><td>843</td><td>tags=83%, list=66%, signal=239%</td></tr><tr><td class='lessen'>667</td><td>REACTOME_PTEN_REGULATION</td><td></td><td>24</td><td>0.12</td><td>0.46</td><td>0.991</td><td>1.000</td><td>1.000</td><td>15</td><td>tags=4%, list=1%, signal=4%</td></tr><tr><td class='lessen'>668</td><td>ENK_UV_RESPONSE_EPIDERMIS_UP</td><td></td><td>40</td><td>0.09</td><td>0.42</td><td>0.993</td><td>1.000</td><td>1.000</td><td>656</td><td>tags=63%, list=52%, signal=125%</td></tr><tr><td class='lessen'>669</td><td>ELVIDGE_HYPOXIA_DN</td><td></td><td>22</td><td>0.11</td><td>0.42</td><td>0.998</td><td>1.000</td><td>1.000</td><td>1132</td><td>tags=100%, list=89%, signal=899%</td></tr><tr><td class='lessen'>670</td><td>SENESE_HDAC1_TARGETS_UP</td><td></td><td>53</td><td>0.09</td><td>0.42</td><td>1.000</td><td>1.000</td><td>1.000</td><td>24</td><td>tags=4%, list=2%, signal=4%</td></tr><tr><td class='lessen'>671</td><td>WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER</td><td></td><td>16</td><td>0.12</td><td>0.41</td><td>0.998</td><td>0.999</td><td>1.000</td><td>1123</td><td>tags=100%, list=88%, signal=848%</td></tr><tr><td class='lessen'>672</td><td>WP_FOCAL_ADHESIONPI3KAKTMTORSIGNALING_PATHWAY</td><td></td><td>30</td><td>0.09</td><td>0.39</td><td>0.998</td><td>1.000</td><td>1.000</td><td>409</td><td>tags=33%, list=32%, signal=48%</td></tr><tr><td class='lessen'>673</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP</td><td></td><td>38</td><td>0.07</td><td>0.33</td><td>0.998</td><td>1.000</td><td>1.000</td><td>313</td><td>tags=24%, list=25%, signal=30%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>na<b>&nbsp<a href='gsea_report_for_na_pos_1605120323325.tsv'>[plain text format]</a></caption></table></div><br></body></html>